BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010;32:129-40. [PMID: 20079667 DOI: 10.1016/j.immuni.2009.11.009] [Cited by in Crossref: 1030] [Cited by in F6Publishing: 932] [Article Influence: 93.6] [Reference Citation Analysis]
Number Citing Articles
1 Pennati A, Ng S, Wu Y, Murphy JR, Deng J, Rangaraju S, Asress S, Blanchfield JL, Evavold B, Galipeau J. Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation. J Neurosci 2016;36:12598-610. [PMID: 27821578 DOI: 10.1523/JNEUROSCI.1994-16.2016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 5.4] [Reference Citation Analysis]
2 Zahran AM, Aly SS, Elabd A, Mohamad IL, Elsayh KI. Regulatory and Memory B Lymphocytes in Children With Newly Diagnosed Immune Thrombocytopenia. J Hematol 2017;6:81-6. [PMID: 32300398 DOI: 10.14740/jh336w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nakayamada S, Iwata S, Tanaka Y. Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus. Int J Rheum Dis 2015;18:208-18. [DOI: 10.1111/1756-185x.12534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
4 Luu VP, Vazquez MI, Zlotnik A. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 2013;47:1-12. [DOI: 10.3109/08916934.2013.856006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
5 Rattik S, Mantani PT, Yao Mattisson I, Ljungcrantz I, Sundius L, Björkbacka H, Terrinoni M, Lebens M, Holmgren J, Nilsson J, Wigren M, Nordin Fredrikson G. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice. Vascular Pharmacology 2018;111:54-61. [DOI: 10.1016/j.vph.2018.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Quan C, ZhangBao J, Lu J, Zhao C, Cai T, Wang B, Yu H, Qiao J, Lu C. The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy. J Neuroimmunol 2015;282:45-53. [PMID: 25903728 DOI: 10.1016/j.jneuroim.2015.03.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
7 Zhou H, Zhan F, Zhang H, Gu J, Mu X, Gao J, Rao J, Ji G, Ni X, Lu L, Xia Y. The proportion of CD19+CD24hiCD27+ regulatory B cells predicts the occurrence of acute allograft rejection in liver transplantation. Ann Transl Med 2019;7:465. [PMID: 31700901 DOI: 10.21037/atm.2019.08.05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Qian L, Qian C, Chen Y, Bai Y, Bao Y, Lu L, Cao X. Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L. Blood 2012;120:581-91. [PMID: 22692512 DOI: 10.1182/blood-2011-08-377242] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
9 Redfield RR, Rodriguez E, Parsons R, Vivek K, Mustafa MM, Noorchashm H, Naji A. Essential role for B cells in transplantation tolerance. Curr Opin Immunol. 2011;23:685-691. [PMID: 21982511 DOI: 10.1016/j.coi.2011.07.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
10 von Borstel A, Lintermans LL, Heeringa P, Rutgers A, Stegeman CA, Sanders JS, Abdulahad WH. Circulating CD24hiCD38hi regulatory B cells correlate inversely with the ThEM17 cell frequency in granulomatosis with polyangiitis patients. Rheumatology (Oxford) 2019. [PMID: 30649475 DOI: 10.1093/rheumatology/key412] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Kotb A, Klippert A, Daskalaki M, Sauermann U, Stahl-Hennig C, Neumann B. Elevated granzyme B+ B-cell level in SIV-infection correlate with viral load and low CD4 T-cell count. Immunol Cell Biol 2017;95:316-20. [PMID: 27779180 DOI: 10.1038/icb.2016.96] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Choi SC, Morel L. B cell contribution of the CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus. Autoimmunity 2017;50:37-41. [PMID: 28166683 DOI: 10.1080/08916934.2017.1280028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Berthelot JM, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P. Regulatory B cells play a key role in immune system balance. Joint Bone Spine. 2013;80:18-22. [PMID: 22858147 DOI: 10.1016/j.jbspin.2012.04.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
14 Piper CJM, Rosser EC, Oleinika K, Nistala K, Krausgruber T, Rendeiro AF, Banos A, Drozdov I, Villa M, Thomson S, Xanthou G, Bock C, Stockinger B, Mauri C. Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B Cells. Cell Rep 2019;29:1878-1892.e7. [PMID: 31722204 DOI: 10.1016/j.celrep.2019.10.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 40.0] [Reference Citation Analysis]
15 Lighaam LC, Unger PA, Vredevoogd DW, Verhoeven D, Vermeulen E, Turksma AW, Ten Brinke A, Rispens T, van Ham SM. In vitro-Induced Human IL-10+ B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory Cytokines. Front Immunol 2018;9:1913. [PMID: 30258433 DOI: 10.3389/fimmu.2018.01913] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
16 Sakkas LI. Regulatory B cells in autoimmune rheumatic diseases. Mediterr J Rheumatol 2017;28:75-9. [PMID: 32185261 DOI: 10.31138/mjr.28.2.75] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sapra L, Bhardwaj A, Mishra PK, Garg B, Verma B, Mishra GC, Srivastava RK. Regulatory B Cells (Bregs) Inhibit Osteoclastogenesis and Play a Potential Role in Ameliorating Ovariectomy-Induced Bone Loss. Front Immunol 2021;12:691081. [PMID: 34276682 DOI: 10.3389/fimmu.2021.691081] [Reference Citation Analysis]
18 San Segundo D, López-hoyos M, Arias M. Regulatory B-Cells in Transplantation. Antibodies 2013;2:587-97. [DOI: 10.3390/antib2040587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Chekol Abebe E, Asmamaw Dejenie T, Mengie Ayele T, Dagnew Baye N, Agegnehu Teshome A, Tilahun Muche Z. The Role of Regulatory B Cells in Health and Diseases: A Systemic Review. J Inflamm Res 2021;14:75-84. [PMID: 33469337 DOI: 10.2147/JIR.S286426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Guan H, Lan Y, Wan Y, Wang Q, Wang C, Xu L, Chen Y, Liu W, Zhang X, Li Y, Gu Y, Wang Z, Xie F. PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in Invasive breast cancer. Oncoimmunology 2016;5:e1075112. [PMID: 27057444 DOI: 10.1080/2162402X.2015.1075112] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
21 Wei YX, Sun B, Xiao L, Shi BY. Infusion of Lymphocytes Treated With 8-Methoxypsoralen and Ultraviolet A Light Induces CD19+IL-10+ Regulatory B Cells and Promotes Skin Allograft Survival. Transplant Proc 2018;50:3906-10. [PMID: 30577285 DOI: 10.1016/j.transproceed.2018.04.066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Berggren O, Hagberg N, Alexsson A, Weber G, Rönnblom L, Eloranta ML. Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype. PLoS One 2017;12:e0183946. [PMID: 28846748 DOI: 10.1371/journal.pone.0183946] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
23 Strom A, Cross A, Cole J, Blair P, Leib C, Goddard M, Rosser E, Park I, Nilsson AH, Nilsson J, Mauri C, Monaco C. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost 2017;114:835-47. [DOI: 10.1160/th14-12-1084] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
24 Aravena O, Ferrier A, Menon M, Mauri C, Aguillón JC, Soto L, Catalán D. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Arthritis Res Ther 2017;19:8. [PMID: 28103916 DOI: 10.1186/s13075-016-1213-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 11.3] [Reference Citation Analysis]
25 Matta B, Barnes BJ. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis. Cytokine 2020;132:154731. [PMID: 31130331 DOI: 10.1016/j.cyto.2019.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Yi JS, Russo MA, Massey JM, Juel V, Hobson-Webb LD, Gable K, Raja SM, Balderson K, Weinhold KJ, Guptill JT. B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity. Front Neurol 2017;8:34. [PMID: 28239367 DOI: 10.3389/fneur.2017.00034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
27 Rolf L, Muris AH, Hupperts R, Damoiseaux J. Illuminating vitamin D effects on B cells--the multiple sclerosis perspective. Immunology 2016;147:275-84. [PMID: 26714674 DOI: 10.1111/imm.12572] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
28 Menon M, Hussell T, Ali Shuwa H. Regulatory B cells in respiratory health and diseases. Immunol Rev 2021;299:61-73. [PMID: 33410165 DOI: 10.1111/imr.12941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
29 Geginat J, Vasco M, Gerosa M, Tas SW, Pagani M, Grassi F, Flavell RA, Meroni P, Abrignani S. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus. Semin Immunol 2019;44:101330. [PMID: 31735515 DOI: 10.1016/j.smim.2019.101330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
30 Chung BH, Kim KW, Yu JH, Kim BM, Choi BS, Park CW, Kim YS, Cho ML, Yang CW. Decrease of immature B cell and interleukin-10 during early-post-transplant period in renal transplant recipients under tacrolimus based immunosuppression. Transpl Immunol 2014;30:159-67. [PMID: 24709525 DOI: 10.1016/j.trim.2014.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
31 Bartosińska J, Purkot J, Karczmarczyk A, Chojnacki M, Zaleska J, Własiuk P, Grząśko N, Morawska M, Walter-Croneck A, Usnarska-Zubkiewicz L, Zielińska P, Jamroziak K, Kowal M, Krasowska D, Chodorowska G, Giannopoulos K. Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma. Cells 2021;10:411. [PMID: 33669402 DOI: 10.3390/cells10020411] [Reference Citation Analysis]
32 Kirchhof MG, Dutz JP. The immunopathology of cutaneous lupus erythematosus. Rheum Dis Clin North Am 2014;40:455-74, viii. [PMID: 25034156 DOI: 10.1016/j.rdc.2014.04.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
33 Thaunat O, Morelon E, Defrance T. Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood 2010;116:515-21. [PMID: 20339090 DOI: 10.1182/blood-2010-01-266668] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
34 Mavropoulos A, Varna A, Zafiriou E, Liaskos C, Alexiou I, Roussaki-schulze A, Vlychou M, Katsiari C, Bogdanos DP, Sakkas LI. IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells. Clinical Immunology 2017;184:33-41. [DOI: 10.1016/j.clim.2017.04.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
35 Forestier A, Guerrier T, Jouvray M, Giovannelli J, Lefèvre G, Sobanski V, Hauspie C, Hachulla E, Hatron PY, Zéphir H, Vermersch P, Labalette M, Launay D, Dubucquoi S. Altered B lymphocyte homeostasis and functions in systemic sclerosis. Autoimmun Rev 2018;17:244-55. [PMID: 29343447 DOI: 10.1016/j.autrev.2017.10.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
36 Bottomley MJ, Thomson J, Harwood C, Leigh I. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E2009. [PMID: 31022866 DOI: 10.3390/ijms20082009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
37 Siewe B, Stapleton JT, Martinson J, Keshavarzian A, Kazmi N, Demarais PM, French AL, Landay A. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro. J Leukoc Biol. 2013;93:811-818. [PMID: 23434518 DOI: 10.1189/jlb.0912436] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 9.3] [Reference Citation Analysis]
38 Zhang M, Zeng G, Yang Q, Zhang J, Zhu X, Chen Q, Suthakaran P, Zhang Y, Deng Q, Liu H, Zhou B, Chen X. Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell. Tuberculosis 2014;94:238-44. [DOI: 10.1016/j.tube.2013.12.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
39 Pan M, Zhu H, Xu R. Immune cellular regulation on autoantibody production in pemphigus. J Dermatol 2015;42:11-7. [DOI: 10.1111/1346-8138.12697] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
40 Lundy SK, Lukacs NW. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front Immunol 2013;4:39. [PMID: 23429492 DOI: 10.3389/fimmu.2013.00039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
41 Sadanand S, Tomayko MM. B Cell Biology. In: Gaspari AA, Tyring SK, Kaplan DH, editors. Clinical and Basic Immunodermatology. Cham: Springer International Publishing; 2017. pp. 97-119. [DOI: 10.1007/978-3-319-29785-9_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Mielle J, Nutz A, Guillpain P, Audo R, Gaujoux-Viala C, Combe B, Morel J, Daien C. IL-10-producing regulatory B cells are present and functional in primary Sjögren patients. Immunol Res 2021;69:107-13. [PMID: 33483936 DOI: 10.1007/s12026-021-09171-x] [Reference Citation Analysis]
43 Poe JC, Smith SH, Haas KM, Yanaba K, Tsubata T, Matsushita T, Tedder TF. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One 2011;6:e22464. [PMID: 21799861 DOI: 10.1371/journal.pone.0022464] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
44 Mok CC. Update on B-cell targeted therapies for systemic lupus erythematosus. Expert Opin Biol Ther 2014;14:773-88. [PMID: 24588110 DOI: 10.1517/14712598.2014.895810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
45 Benfaremo D, Gabrielli A. Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases? Cells 2019;9:E77. [PMID: 31892266 DOI: 10.3390/cells9010077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Hinz D, Seumois G, Gholami AM, Greenbaum JA, Lane J, White B, Broide DH, Schulten V, Sidney J, Bakhru P, Oseroff C, Wambre E, James EA, Kwok WW, Peters B, Vijayanand P, Sette A. Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity. Clin Exp Allergy 2016;46:705-19. [PMID: 26662458 DOI: 10.1111/cea.12692] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
47 Ickrath P, Kleinsasser N, Ding X, Ginzkey C, Beyersdorf N, Kerkau T, Hagen R, Hackenberg S. Impact and Modulations of Peripheral and Edaphic B Cell Subpopulations in Chronic Rhinosinusitis With Nasal Polyposis. Clin Exp Otorhinolaryngol 2018;11:133-40. [PMID: 29409312 DOI: 10.21053/ceo.2017.01389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
48 Miyazaki Y, Niino M, Takahashi E, Suzuki M, Mizuno M, Hisahara S, Fukazawa T, Amino I, Nakano F, Nakamura M, Akimoto S, Minami N, Fujiki N, Doi S, Shimohama S, Terayama Y, Kikuchi S. Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis. Clinical Immunology 2018;187:95-101. [DOI: 10.1016/j.clim.2017.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
49 Rolf L, Muris A, Hupperts R, Damoiseaux J. Vitamin D effects on B cell function in autoimmunity: Vitamin D effects on B cells. Ann N Y Acad Sci 2014;1317:84-91. [DOI: 10.1111/nyas.12440] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
50 Thompson WS, Pekalski ML, Simons HZ, Smyth DJ, Castro-Dopico X, Guo H, Guy C, Dunger DB, Arif S, Peakman M, Wallace C, Wicker LS, Todd JA, Ferreira RC. Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes. Clin Exp Immunol 2014;177:571-85. [PMID: 24773525 DOI: 10.1111/cei.12362] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
51 Piloni D, Morosini M, Magni S, Balderacchi A, Inghilleri S, Cova E, Oggionni T, Frangipane V, Pandolfi L, Scudeller L, Meloni F. Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients. Transplant Immunology 2019;57:101245. [DOI: 10.1016/j.trim.2019.101245] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Verma D, Chan ED, Ordway DJ. The double-edged sword of Tregs in M tuberculosis, M avium, and M absessus infection. Immunol Rev 2021;301:48-61. [PMID: 33713043 DOI: 10.1111/imr.12959] [Reference Citation Analysis]
53 Tai YT, Lin L, Xing L, Cho SF, Yu T, Acharya C, Wen K, Hsieh PA, Dulos J, van Elsas A, Munshi N, Richardson P, Anderson KC. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia 2019;33:426-38. [PMID: 30135465 DOI: 10.1038/s41375-018-0242-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
54 Rincón-Arévalo H, Sanchez-Parra CC, Castaño D, Yassin L, Vásquez G. Regulatory B Cells and Mechanisms. Int Rev Immunol 2016;35:156-76. [PMID: 25793964 DOI: 10.3109/08830185.2015.1015719] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
55 Wang Y, Qin Y, Wang X, Zhang L, Wang J, Xu X, Chen H, Hsu HT, Zhang M. Decrease in the proportion of CD24hi CD38hi B cells and impairment of their regulatory capacity in type 1 diabetes patients. Clin Exp Immunol 2020;200:22-32. [PMID: 31849037 DOI: 10.1111/cei.13408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
56 Hamilton JA, Hsu HC, Mountz JD. Autoreactive B cells in SLE, villains or innocent bystanders? Immunol Rev 2019;292:120-38. [PMID: 31631359 DOI: 10.1111/imr.12815] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
57 Sarvaria A, Basar R, Mehta RS, Shaim H, Muftuoglu M, Khoder A, Sekine T, Gokdemir E, Kondo K, Marin D, Daher M, Alousi AM, Alsuliman A, Liu E, Oran B, Olson A, Jones RB, Popat U, Hosing C, Champlin R, Shpall EJ, Rezvani K. IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation. Blood 2016;128:1346-61. [PMID: 27439912 DOI: 10.1182/blood-2016-01-695122] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
58 Vinay DS, Lee SJ, Kim CH, Oh HS, Kwon BS. Exposure of a distinct PDCA-1+ (CD317) B cell population to agonistic anti-4-1BB (CD137) inhibits T and B cell responses both in vitro and in vivo. PLoS One 2012;7:e50272. [PMID: 23185591 DOI: 10.1371/journal.pone.0050272] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
59 Schroth J, Thiemermann C, Henson SM. Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease. Front Cell Dev Biol 2020;8:564461. [PMID: 33163486 DOI: 10.3389/fcell.2020.564461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
60 He Y, Yuan X, Li Y, Zhong C, Liu Y, Qian H, Xuan J, Duan L, Shi G. Loss of Gαq impairs regulatory B-cell function. Arthritis Res Ther 2018;20:186. [PMID: 30143054 DOI: 10.1186/s13075-018-1682-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Singh A, Ramachandran S, Graham ML, Daneshmandi S, Heller D, Suarez-Pinzon WL, Balamurugan AN, Ansite JD, Wilhelm JJ, Yang A, Zhang Y, Palani NP, Abrahante JE, Burlak C, Miller SD, Luo X, Hering BJ. Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes. Nat Commun 2019;10:3495. [PMID: 31375697 DOI: 10.1038/s41467-019-11338-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
62 Lundy SK, Wu Q, Wang Q, Dowling CA, Taitano SH, Mao G, Mao-Draayer Y. Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets. Neurol Neuroimmunol Neuroinflamm 2016;3:e211. [PMID: 27006972 DOI: 10.1212/NXI.0000000000000211] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 10.2] [Reference Citation Analysis]
63 Kelly AM, McLoughlin RM. Target the Host, Kill the Bug; Targeting Host Respiratory Immunosuppressive Responses as a Novel Strategy to Improve Bacterial Clearance During Lung Infection. Front Immunol 2020;11:767. [PMID: 32425944 DOI: 10.3389/fimmu.2020.00767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Marian V, Anolik JH. Treatment targets in systemic lupus erythematosus: biology and clinical perspective. Arthritis Res Ther 2012;14 Suppl 4:S3. [PMID: 23281796 DOI: 10.1186/ar3917] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
65 Lemoine S, Morva A, Youinou P, Jamin C. Human T cells induce their own regulation through activation of B cells. J Autoimmun. 2011;36:228-238. [PMID: 21316922 DOI: 10.1016/j.jaut.2011.01.005] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 11.1] [Reference Citation Analysis]
66 Shuwa HA, Shaw TN, Knight SB, Wemyss K, McClure FA, Pearmain L, Prise I, Jagger C, Morgan DJ, Khan S, Brand O, Mann ER, Ustianowski A, Bakerly ND, Dark P, Brightling CE, Brij S, Felton T, Simpson A, Grainger JR, Hussell T, Konkel JE, Menon M; CIRCO. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med (N Y) 2021;2:720-735.e4. [PMID: 33821250 DOI: 10.1016/j.medj.2021.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Bird AK, Meednu N, Anolik JH. New insights into B cell biology in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 2015;27:461-7. [PMID: 26164595 DOI: 10.1097/BOR.0000000000000201] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
68 Zhu HQ, Xu RC, Chen YY, Yuan HJ, Cao H, Zhao XQ, Zheng J, Wang Y, Pan M. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus. Br J Dermatol 2015;172:101-10. [PMID: 24935080 DOI: 10.1111/bjd.13192] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
69 Hong M, Liao Y, Liang J, Chen X, Li S, Liu W, Gao C, Zhong Z, Kong D, Deng J, Zhang J, Pan G. Immunomodulation of human CD19+CD25high regulatory B cells via Th17/Foxp3 regulatory T cells and Th1/Th2 cytokines. Human Immunology 2019;80:863-70. [DOI: 10.1016/j.humimm.2019.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
70 Bouma G, Carter NA, Recher M, Malinova D, Adriani M, Notarangelo LD, Burns SO, Mauri C, Thrasher AJ. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells. Eur J Immunol 2014;44:2692-702. [PMID: 24945741 DOI: 10.1002/eji.201344245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
71 Zheng Y, Ge W, Ma Y, Xie G, Wang W, Han L, Bian B, Li L, Shen L. miR-155 Regulates IL-10-Producing CD24hiCD27+ B Cells and Impairs Their Function in Patients with Crohn's Disease. Front Immunol 2017;8:914. [PMID: 28824639 DOI: 10.3389/fimmu.2017.00914] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
72 Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, Bassi R, D’Addio F, Schatton T, Abdi R. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes. 2015;64:158-171. [PMID: 25187361 DOI: 10.2337/db13-1639] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
73 de Masson A, Socié G, Bagot M, Bensussan A, Bouaziz JD. Deficient regulatory B cells in human chronic graft-versus-host disease. Oncoimmunology 2015;4:e1016707. [PMID: 26140245 DOI: 10.1080/2162402X.2015.1016707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
74 Ding T, Yan F, Cao S, Ren X. Regulatory B cell: New member of immunosuppressive cell club. Hum Immunol. 2015;76:615-621. [PMID: 26385479 DOI: 10.1016/j.humimm.2015.09.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
75 Khan AR, Amu S, Saunders SP, Hams E, Blackshields G, Leonard MO, Weaver CT, Sparwasser T, Sheils O, Fallon PG. Ligation of TLR7 on CD19(+) CD1d(hi) B cells suppresses allergic lung inflammation via regulatory T cells. Eur J Immunol 2015;45:1842-54. [PMID: 25763771 DOI: 10.1002/eji.201445211] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
76 Simon Q, Pers J, Cornec D, Le Pottier L, Mageed RA, Hillion S. In-depth characterization of CD24 high CD38 high transitional human B cells reveals different regulatory profiles. Journal of Allergy and Clinical Immunology 2016;137:1577-1584.e10. [DOI: 10.1016/j.jaci.2015.09.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 9.8] [Reference Citation Analysis]
77 Yazdanbakhsh K. cGVHD B(r)egs to differ. Blood 2014;124:2005-6. [PMID: 25258134 DOI: 10.1182/blood-2014-08-592295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 Rabani M, Wilde B, Hübbers K, Xu S, Kribben A, Witzke O, Dolff S. IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis. Clin Immunol 2018;188:45-51. [PMID: 29274388 DOI: 10.1016/j.clim.2017.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
79 Burlock B, Richardson G, García-Rodríguez S, Guerrero S, Zubiaur M, Sancho J. The Role of CD38 on the Function of Regulatory B Cells in a Murine Model of Lupus. Int J Mol Sci 2018;19:E2906. [PMID: 30257456 DOI: 10.3390/ijms19102906] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
80 Khan AR, Hams E, Floudas A, Sparwasser T, Weaver CT, Fallon PG. PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun 2015;6. [DOI: 10.1038/ncomms6997] [Cited by in Crossref: 156] [Cited by in F6Publishing: 144] [Article Influence: 26.0] [Reference Citation Analysis]
81 Ye Z, Jiang Y, Sun D, Zhong W, Zhao L, Jiang Z. The Plasma Interleukin (IL)-35 Level and Frequency of Circulating IL-35+ Regulatory B Cells are Decreased in a Cohort of Chinese Patients with New-onset Systemic Lupus Erythematosus. Sci Rep 2019;9:13210. [PMID: 31519970 DOI: 10.1038/s41598-019-49748-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
82 Xiao W, Salem D, McCoy CS, Lee D, Shah NN, Stetler-Stevenson M, Yuan CM. Early recovery of circulating immature B cells in B-lymphoblastic leukemia patients after CD19 targeted CAR T cell therapy: A pitfall for minimal residual disease detection. Cytometry B Clin Cytom 2018;94:434-43. [PMID: 28888074 DOI: 10.1002/cyto.b.21591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
83 Daien CI, Gailhac S, Mura T, Audo R, Combe B, Hahne M, Morel J. Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease Activity: Relationship of B10 Cells to RA Disease Activity. Arthritis & Rheumatology 2014;66:2037-46. [DOI: 10.1002/art.38666] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 12.6] [Reference Citation Analysis]
84 Seddiki N, Brezar V, Draenert R. Cell exhaustion in HIV-1 infection: role of suppressor cells. Curr Opin HIV AIDS 2014;9:452-8. [PMID: 25010895 DOI: 10.1097/COH.0000000000000087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
85 Wei C, Jenks S, Sanz I. Polychromatic flow cytometry in evaluating rheumatic disease patients. Arthritis Res Ther 2015;17:46. [PMID: 25880288 DOI: 10.1186/s13075-015-0561-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
86 Mozo L, López P, Caminal-Montero L, Rodríguez-Carrio J, Suárez A. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients. Lupus 2014;23:1477-85. [PMID: 25107939 DOI: 10.1177/0961203314546020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
87 Rincón-Arévalo H, Quintero JC, Fortich F, Rojas M, Vásquez G, Castaño D, Yassin LM. Low frequency of IL-10+ B cells in patients with atherosclerosis is related with inflammatory condition. Heliyon 2020;6:e03441. [PMID: 32154409 DOI: 10.1016/j.heliyon.2020.e03441] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
88 Zhou M, Wen Z, Cheng F, Ma J, Li W, Ren H, Sheng Y, Dong H, Lu L, Hu HM, Wang LX. Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway. Oncoimmunology 2016;5:e1180485. [PMID: 27622036 DOI: 10.1080/2162402X.2016.1180485] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
89 Chesneau M, Michel L, Degauque N, Brouard S. Regulatory B cells and tolerance in transplantation: from animal models to human. Front Immunol. 2013;4:497. [PMID: 24427159 DOI: 10.3389/fimmu.2013.00497] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
90 Karahan GE, Claas FH, Heidt S. B Cell Immunity in Solid Organ Transplantation. Front Immunol 2016;7:686. [PMID: 28119695 DOI: 10.3389/fimmu.2016.00686] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
91 Perez-Andres M, Paiva B, Nieto WG, Caraux A, Schmitz A, Almeida J, Vogt RF Jr, Marti GE, Rawstron AC, Van Zelm MC, Van Dongen JJ, Johnsen HE, Klein B, Orfao A; Primary Health Care Group of Salamanca for the Study of MBL. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin Cytom 2010;78 Suppl 1:S47-60. [PMID: 20839338 DOI: 10.1002/cyto.b.20547] [Cited by in Crossref: 164] [Cited by in F6Publishing: 141] [Article Influence: 14.9] [Reference Citation Analysis]
92 Volchenkov R, Karlsen M, Jonsson R, Appel S. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scand J Immunol. 2013;77:246-254. [PMID: 23442246 DOI: 10.1111/sji.12039] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
93 Furuzawa-Carballeda J, Sánchez-Guerrero J, Betanzos JL, Enriquez AB, Avila-Casado C, Llorente L, Hernández-Molina G. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren’s syndrome. Scand J Immunol. 2014;80:432-440. [PMID: 25346207 DOI: 10.1111/sji.12224] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
94 Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 2013;131:1674-82. [PMID: 23534976 DOI: 10.1016/j.jaci.2013.01.044] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
95 Tonon S, Mion F, Dong J, Chang HD, Dalla E, Scapini P, Perruolo G, Zanello A, Dugo M, Cassatella MA, Colombo MP, Radbruch A, Tripodo C, Pucillo CE. IL-10-producing B cells are characterized by a specific methylation signature. Eur J Immunol 2019;49:1213-25. [PMID: 31034584 DOI: 10.1002/eji.201848025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
96 Sim JH, Kim HR, Chang SH, Kim IJ, Lipsky PE, Lee J. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus. Arthritis Res Ther 2015;17:190. [PMID: 26209442 DOI: 10.1186/s13075-015-0687-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
97 Adlowitz DG, Barnard J, Biear JN, Cistrone C, Owen T, Wang W, Palanichamy A, Ezealah E, Campbell D, Wei C, Looney RJ, Sanz I, Anolik JH. Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response. PLoS One 2015;10:e0128269. [PMID: 26047509 DOI: 10.1371/journal.pone.0128269] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 14.3] [Reference Citation Analysis]
98 Wang YY, Zhang L, Zhao PW, Ma L, Li C, Zou HB, Jiang YF. Functional implications of regulatory B cells in human IgA nephropathy. Scand J Immunol 2014;79:51-60. [PMID: 24219615 DOI: 10.1111/sji.12128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
99 Duggal NA, Upton J, Phillips AC, Lord JM. Development of depressive symptoms post hip fracture is associated with altered immunosuppressive phenotype in regulatory T and B lymphocytes. Biogerontology 2016;17:229-39. [PMID: 26112234 DOI: 10.1007/s10522-015-9587-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
100 Lino AC, Dörner T, Bar-Or A, Fillatreau S. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases. Immunol Rev 2016;269:130-44. [PMID: 26683150 DOI: 10.1111/imr.12374] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
101 Cui HD, Qi ZM, Yang LL, Qi L, Zhang N, Zhang XL, Du SY, Jiang Y. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients. Clin Exp Immunol 2011;165:163-71. [PMID: 21635228 DOI: 10.1111/j.1365-2249.2011.04424.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
102 Yang SH, Gao CY, Li L, Chang C, Leung PSC, Gershwin ME, Lian ZX. The molecular basis of immune regulation in autoimmunity. Clin Sci (Lond) 2018;132:43-67. [PMID: 29305419 DOI: 10.1042/CS20171154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
103 Gheybi MK, Farrokhi S, Ravanbod MR, Ostovar A, Mehrzad V, Nematollahi P. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients. Breast Cancer 2017;24:756-64. [DOI: 10.1007/s12282-017-0775-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
104 Rezk A, Li R, Bar-Or A. Multiplexed detection and isolation of viable low-frequency cytokine-secreting human B cells using cytokine secretion assay and flow cytometry (CSA-Flow). Sci Rep 2020;10:14823. [PMID: 32908164 DOI: 10.1038/s41598-020-71750-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
105 Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR. Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine 2015;74:27-34. [PMID: 25481648 DOI: 10.1016/j.cyto.2014.10.031] [Cited by in Crossref: 150] [Cited by in F6Publishing: 127] [Article Influence: 21.4] [Reference Citation Analysis]
106 Yu S, Qi Y, Wang H, Jiang J, Sun L, Zhou Q. Dysfunction of CD24+CD38+ B cells in patients with Hashimoto’s thyroiditis is associated with a lack of interleukin 10. The International Journal of Biochemistry & Cell Biology 2017;90:114-20. [DOI: 10.1016/j.biocel.2017.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
107 Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M, Alber DG, Krausgruber T, Catalan D, Klein N, Manson JJ, Drozdov I, Bock C, Wedderburn LR, Eaton S, Mauri C. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab 2020;31:837-851.e10. [PMID: 32213346 DOI: 10.1016/j.cmet.2020.03.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 65.0] [Reference Citation Analysis]
108 Wang S, Qin C. Interleukin 35 Rescues Regulatory B Cell Function, but the Effect Is Dysregulated in Ulcerative Colitis. DNA and Cell Biology 2017;36:413-21. [DOI: 10.1089/dna.2016.3570] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
109 Qiu L, Zhou Y, Yu Q, Yu J, Li Q, Sun R. Decreased levels of regulatory B cells in patients with acute pancreatitis: association with the severity of the disease. Oncotarget 2018;9:36067-82. [PMID: 30546828 DOI: 10.18632/oncotarget.23911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Fleischer SJ, Giesecke C, Mei HE, Lipsky PE, Daridon C, Dörner T. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Arthritis Rheumatol 2014;66:3424-35. [PMID: 25156507 DOI: 10.1002/art.38854] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
111 Noh G, Lee JH. Regulatory B cells and allergic diseases. Allergy Asthma Immunol Res. 2011;3:168-177. [PMID: 21738882 DOI: 10.4168/aair.2011.3.3.168] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
112 Birk NM, Nissen TN, Kjærgaard J, Hartling HJ, Thøstesen LM, Kofoed PE, Stensballe LG, Andersen A, Pryds O, Netea MG, Benn CS, Nielsen SD, Jeppesen DL. Effects of Bacillus Calmette-Guérin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial. Sci Rep 2017;7:12398. [PMID: 28963455 DOI: 10.1038/s41598-017-11601-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
113 Tao L, Wang Y, Xu J, Su J, Yang Q, Deng W, Zou B, Tan Y, Ding Z, Li X. IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock. Pharmacol Res 2019;148:104457. [PMID: 31536782 DOI: 10.1016/j.phrs.2019.104457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
114 Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre M, Dreno B, Franck N, Ingen-housz-oro S, Chosidow O, Pauwels C, Picard C, Roujeau J, Sigal M, Tancrede-bohin E, Templier I, Eming R, Hertl M, D'incan M, Joly P, Musette P. Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response. Science Translational Medicine 2013;5:175ra30-175ra30. [DOI: 10.1126/scitranslmed.3005166] [Cited by in Crossref: 135] [Cited by in F6Publishing: 122] [Article Influence: 16.9] [Reference Citation Analysis]
115 Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol. 2013;10:122-132. [PMID: 23292280 DOI: 10.1038/cmi.2012.60] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 15.9] [Reference Citation Analysis]
116 Dai X, Zhao W, Zhan J, Zeng S, Ran D, Zhang H, Song Z, Song KH, Wu L. B cells present skewed profile and lose the function of supporting T cell inflammation after Roux-en-Y gastric bypass. Int Immunopharmacol 2017;43:16-22. [PMID: 27936460 DOI: 10.1016/j.intimp.2016.11.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
117 Holm SR, Jenkins BJ, Cronin JG, Jones N, Thornton CA. A role for metabolism in determining neonatal immune function. Pediatr Allergy Immunol 2021. [PMID: 34170575 DOI: 10.1111/pai.13583] [Reference Citation Analysis]
118 Colucci M, Carsetti R, Cascioli S, Casiraghi F, Perna A, Ravà L, Ruggiero B, Emma F, Vivarelli M. B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome. J Am Soc Nephrol 2016;27:1811-22. [PMID: 26567244 DOI: 10.1681/ASN.2015050523] [Cited by in Crossref: 78] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
119 Wang L, Fu Y, Yu B, Jiang X, Liu H, Liu J, Zha B, Chu Y. HSP70, a Novel Regulatory Molecule in B Cell-Mediated Suppression of Autoimmune Diseases. J Mol Biol 2021;433:166634. [PMID: 32860772 DOI: 10.1016/j.jmb.2020.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
120 Dörner T, Shock A, Goldenberg DM, Lipsky PE. The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Autoimmun Rev 2015;14:1079-86. [PMID: 26212727 DOI: 10.1016/j.autrev.2015.07.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
121 Hoffmann F, Meinl E. B cells in multiple sclerosis: good or bad guys?: An article for 28 May 2014 - World MS Day 2014. Eur J Immunol 2014;44:1247-50. [PMID: 24771624 DOI: 10.1002/eji.201470045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
122 Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M. Diagnostic Approach to the Complexity of IgG4-Related Disease. Mayo Clin Proc 2015;90:927-39. [PMID: 26141331 DOI: 10.1016/j.mayocp.2015.03.020] [Cited by in Crossref: 107] [Cited by in F6Publishing: 80] [Article Influence: 17.8] [Reference Citation Analysis]
123 Pillai S, Mattoo H, Cariappa A. B cells and autoimmunity. Curr Opin Immunol. 2011;23:721-731. [PMID: 22119110 DOI: 10.1016/j.coi.2011.10.007] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
124 Kim KW, Chung BH, Jeon EJ, Kim BM, Choi BS, Park CW, Kim YS, Cho SG, Cho ML, Yang CW. B cell-associated immune profiles in patients with end-stage renal disease (ESRD). Exp Mol Med. 2012;44:465-472. [PMID: 22617684 DOI: 10.3858/emm.2012.44.8.053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
125 Anolik J. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus 2013;22:342-9. [DOI: 10.1177/0961203312471576] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
126 Li T, Yu Z, Qu Z, Zhang N, Crew R, Jiang Y. Decreased number of CD19+CD24hiCD38hi regulatory B cells in Diabetic nephropathy. Mol Immunol 2019;112:233-9. [PMID: 31181422 DOI: 10.1016/j.molimm.2019.05.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
127 Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR. Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial. Lancet 2018;391:2619-30. [PMID: 29910042 DOI: 10.1016/S0140-6736(18)30984-X] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 14.3] [Reference Citation Analysis]
128 van der Geest KS, Lorencetti PG, Abdulahad WH, Horst G, Huitema M, Roozendaal C, Kroesen BJ, Brouwer E, Boots AM. Aging-dependent decline of IL-10 producing B cells coincides with production of antinuclear antibodies but not rheumatoid factors. Exp Gerontol 2016;75:24-9. [PMID: 26721376 DOI: 10.1016/j.exger.2015.12.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
129 Wang L, Ni M, Hückelhoven-Krauss A, Sellner L, Hoffmann JM, Neuber B, Luft T, Hegenbart U, Schönland S, Kleist C, Sill M, Chen BA, Wuchter P, Eckstein V, Krüger W, Hilgendorf I, Yerushalmi R, Nagler A, Müller-Tidow C, Ho AD, Dreger P, Schmitt M, Schmitt A. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects. Front Immunol 2018;9:2207. [PMID: 30349527 DOI: 10.3389/fimmu.2018.02207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
130 Luo J, Guo H, Liu Z, Peng T, Hu X, Han M, Yang X, Zhou X, Li H. Analysis of Peripheral B Cell Subsets in Patients With Allergic Rhinitis. Allergy Asthma Immunol Res 2018;10:236-43. [PMID: 29676070 DOI: 10.4168/aair.2018.10.3.236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
131 Ray A, Khalil MI, Pulakanti KL, Burns RT, Gurski CJ, Basu S, Wang D, Rao S, Dittel BN. Mature IgDlow/- B cells maintain tolerance by promoting regulatory T cell homeostasis. Nat Commun 2019;10:190. [PMID: 30643147 DOI: 10.1038/s41467-018-08122-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
132 Shabir S, Girdlestone J, Briggs D, Kaul B, Smith H, Daga S, Chand S, Jham S, Navarrete C, Harper L. Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study. Am J Transplant. 2015;15:1384-1391. [PMID: 25808898 DOI: 10.1111/ajt.13122] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
133 Llanos C, Mackern-Oberti JP, Vega F, Jacobelli SH, Kalergis AM. Tolerogenic dendritic cells as a therapy for treating lupus. Clin Immunol 2013;148:237-45. [PMID: 23773922 DOI: 10.1016/j.clim.2013.04.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
134 Zhang Y, Gallastegui N, Rosenblatt JD. Regulatory B cells in anti-tumor immunity. Int Immunol 2015;27:521-30. [PMID: 25999597 DOI: 10.1093/intimm/dxv034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 11.3] [Reference Citation Analysis]
135 Iwata S, Yamaoka K, Niiro H, Nakano K, Wang S, Akashi K, Tanaka Y. Amplification of Toll-like receptor–mediated signaling through spleen tyrosine kinase in human B-cell activation. Journal of Allergy and Clinical Immunology 2012;129:1594-1601.e2. [DOI: 10.1016/j.jaci.2012.03.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
136 Baglaenko Y, Manion KP, Chang NH, Gracey E, Loh C, Wither JE. IL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone Mice. PLoS One 2016;11:e0150515. [PMID: 26964093 DOI: 10.1371/journal.pone.0150515] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
137 Zhou Y, Zhang Y, Han J, Yang M, Zhu J, Jin T. Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases. J Transl Med 2020;18:131. [PMID: 32183811 DOI: 10.1186/s12967-020-02289-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
138 Rossi M, Gentile M, Toscano R, Recchia AG, Bossio S, Caruso N, De Stefano L, Granata T, Pellicanò M, Vigna E, Tagliaferri P, Tassone P, Morabito F. Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 2013;55:1394-6. [DOI: 10.3109/10428194.2013.824078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
139 Gualtierotti R, Biggioggero M, Penatti A, Meroni P. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmunity Reviews 2010;10:3-7. [DOI: 10.1016/j.autrev.2010.09.007] [Cited by in Crossref: 129] [Cited by in F6Publishing: 110] [Article Influence: 11.7] [Reference Citation Analysis]
140 Clatworthy MR. B cell modulation in transplantation. Clin Exp Immunol 2014;178 Suppl 1:61-3. [PMID: 25546764 DOI: 10.1111/cei.12513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
141 Bakchoul T, Sachs UJ. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms. Hamostaseologie 2016;36:187-94. [PMID: 25982994 DOI: 10.5482/HAMO-14-09-0043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
142 Beckett J, Hester J, Issa F, Shankar S. Regulatory B cells in transplantation: roadmaps to clinic. Transpl Int 2020;33:1353-68. [PMID: 32725703 DOI: 10.1111/tri.13706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
143 Zhang Y, Zhou L, Gu G, Feng M, Ding X, Xia Q, Lu L. CXCL8 high inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression. Immunol Cell Biol 2020;98:682-92. [DOI: 10.1111/imcb.12366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
144 Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 2012;36:477-90. [PMID: 22406267 DOI: 10.1016/j.immuni.2012.02.008] [Cited by in Crossref: 142] [Cited by in F6Publishing: 122] [Article Influence: 15.8] [Reference Citation Analysis]
145 Giannoukakis N, Trucco M. A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2012;19:279-87. [PMID: 22760513 DOI: 10.1097/MED.0b013e328355461b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
146 Scapini P, Lamagna C, Hu Y, Lee K, Tang Q, DeFranco AL, Lowell CA. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc Natl Acad Sci U S A 2011;108:E823-32. [PMID: 21911371 DOI: 10.1073/pnas.1107913108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
147 Suárez-Sánchez FJ, Lequerica-Fernández P, Rodrigo JP, Hermida-Prado F, Suárez-Canto J, Rodríguez-Santamarta T, Domínguez-Iglesias F, García-Pedrero JM, de Vicente JC. Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment. Cancers (Basel) 2021;13:395. [PMID: 33494389 DOI: 10.3390/cancers13030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Brinas F, Danger R, Brouard S. TCL1A, B Cell Regulation and Tolerance in Renal Transplantation. Cells 2021;10:1367. [PMID: 34206047 DOI: 10.3390/cells10061367] [Reference Citation Analysis]
149 Fillatreau S. Regulatory functions of B cells and regulatory plasma cells. Biomed J 2019;42:233-42. [PMID: 31627865 DOI: 10.1016/j.bj.2019.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
150 Zhao M, Duan N, Wang Y, Zhu H, Liu H, Wang H, Xing L, Shao Z. CD5 + B lymphocytes secrete IL-10 rather than TGF-β1 which control the immune response in autoimmune haemolytic anaemia/Evans syndrome. Autoimmunity 2019;52:12-20. [DOI: 10.1080/08916934.2019.1576644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
151 Doherty DG, Melo AM, Moreno-Olivera A, Solomos AC. Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells. Front Immunol 2018;9:1360. [PMID: 29967611 DOI: 10.3389/fimmu.2018.01360] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
152 van der Vlugt LEPM, Zinsou JF, Ozir-fazalalikhan A, Kremsner PG, Yazdanbakhsh M, Adegnika AA, Smits HH. Interleukin 10 (IL-10)–Producing CD1dhi Regulatory B Cells From Schistosoma Haematobium–Infected Individuals Induce IL-10–Positive T Cells and Suppress Effector T-Cell Cytokines. The Journal of Infectious Diseases 2014;210:1207-16. [DOI: 10.1093/infdis/jiu257] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
153 Fehres CM, van Uden NO, Yeremenko NG, Fernandez L, Franco Salinas G, van Duivenvoorde LM, Huard B, Morel J, Spits H, Hahne M, Baeten DLP. APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1. Front Immunol 2019;10:1368. [PMID: 31258536 DOI: 10.3389/fimmu.2019.01368] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
154 Margry B, Kersemakers SC, Hoek A, Arkesteijn GJ, Wieland WH, van Eden W, Broere F. Activated peritoneal cavity B-1a cells possess regulatory B cell properties. PLoS One 2014;9:e88869. [PMID: 24551182 DOI: 10.1371/journal.pone.0088869] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
155 Fu Y, Zhang Z, Yang Z, Jiang Y, Han X, Xu J, Chu Z, Ding H, He S, Shang H. CD27-CD38+ B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression. Cell Rep 2021;36:109344. [PMID: 34260905 DOI: 10.1016/j.celrep.2021.109344] [Reference Citation Analysis]
156 Cardoso D, Perucha E. Cholesterol metabolism: a new molecular switch to control inflammation. Clin Sci (Lond) 2021;135:1389-408. [PMID: 34086048 DOI: 10.1042/CS20201394] [Reference Citation Analysis]
157 Ibrahim EH, Aly M, Morath C, Sayed DM, Ekpoom N, Opelz G, Süsal C, Daniel V. Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients. Immun Inflamm Dis 2021. [PMID: 34102006 DOI: 10.1002/iid3.473] [Reference Citation Analysis]
158 Song H, Xi J, Li GG, Xu S, Wang C, Cheng T, Li H, Zhang Y, Liu X, Bai J. Upregulation of CD19⁺CD24(hi)CD38(hi) regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients. Intern Emerg Med 2016;11:415-23. [PMID: 26758063 DOI: 10.1007/s11739-015-1377-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
159 Liu Y, Duan WR, Liu S, Liu T, Chang YJ, Fan XM. Correlation of CD19+CD24hiCD38hi B cells in coronary artery disease with severity of atherosclerosis. Chin Med J (Engl) 2020;133:1257-8. [PMID: 32433064 DOI: 10.1097/CM9.0000000000000765] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Mauri C, Blair PA. The incognito journey of a regulatory B cell. Immunity 2014;41:878-80. [PMID: 25526301 DOI: 10.1016/j.immuni.2014.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
161 Lawrie S, Bar-or A. B cells set trends: Lessons from multiple sclerosis. Clin Exp Neuroimmunol 2012;3:89-108. [DOI: 10.1111/j.1759-1961.2012.00029.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
162 Thaunat O. Humoral immunity in chronic allograft rejection: Puzzle pieces come together. Transplant Immunology 2012;26:101-6. [DOI: 10.1016/j.trim.2011.11.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
163 Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012;12:417-30. [DOI: 10.1038/nri3227] [Cited by in Crossref: 311] [Cited by in F6Publishing: 262] [Article Influence: 34.6] [Reference Citation Analysis]
164 Bugatti S, Vitolo B, Caporali R, Montecucco C, Manzo A. B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. Biomed Res Int. 2014;2014:681678. [PMID: 24877127 DOI: 10.1155/2014/681678] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 10.7] [Reference Citation Analysis]
165 Moreau A, Blair PA, Chai JG, Ratnasothy K, Stolarczyk E, Alhabbab R, Rackham CL, Jones PM, Smyth L, Elgueta R. Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival. Eur J Immunol. 2015;45:843-853. [PMID: 25408265 DOI: 10.1002/eji.201445082] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
166 Andrews SF, Wilson PC. The anergic B cell. Blood 2010;115:4976-8. [PMID: 20558622 DOI: 10.1182/blood-2010-03-276352] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
167 Nissen TN, Birk NM, Kjærgaard J. Nonspecific Effects of Neonatal Bacille Calmette-Guérin (BCG) Vaccination—From West African Observations to a Danish Randomized Clinical Trial. The Value of BCG and TNF in Autoimmunity. Elsevier; 2018. pp. 91-108. [DOI: 10.1016/b978-0-12-814603-3.00007-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
168 Han J, Sun L, Fan X, Wang Z, Cheng Y, Zhu J, Jin T. Role of regulatory b cells in neuroimmunologic disorders. J Neurosci Res 2016;94:693-701. [PMID: 27112131 DOI: 10.1002/jnr.23749] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
169 Gorosito Serrán M, Fiocca Vernengo F, Beccaria CG, Acosta Rodriguez EV, Montes CL, Gruppi A. The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production. FEBS Lett 2015;589:3362-9. [PMID: 26424657 DOI: 10.1016/j.febslet.2015.08.048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
170 Noonan AM, Farren MR, Geyer SM, Huang Y, Tahiri S, Ahn D, Mikhail S, Ciombor KK, Pant S, Aparo S. Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma. Mol Ther. 2016;24:1150-1158. [PMID: 27039845 DOI: 10.1038/mt.2016.66] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 12.8] [Reference Citation Analysis]
171 Zha B, Wang L, Liu X, Liu J, Chen Z, Xu J, Sheng L, Li Y, Chu Y. Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease. PLoS One 2012;7:e49835. [PMID: 23189166 DOI: 10.1371/journal.pone.0049835] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
172 Rosser EC, Mauri C. The emerging field of regulatory B cell immunometabolism. Cell Metab 2021;33:1088-97. [PMID: 34077716 DOI: 10.1016/j.cmet.2021.05.008] [Reference Citation Analysis]
173 Toubi E, Nussbaum S, Staun-Ram E, Snir A, Melamed D, Hayardeny L, Miller A. Laquinimod modulates B cells and their regulatory effects on T cells in multiple sclerosis. J Neuroimmunol 2012;251:45-54. [PMID: 22846497 DOI: 10.1016/j.jneuroim.2012.07.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
174 Dumoitier N, Terrier B, London J, Lofek S, Mouthon L. Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides. Autoimmunity Reviews 2015;14:996-1004. [DOI: 10.1016/j.autrev.2015.06.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
175 Soto L, Ferrier A, Aravena O, Fonseca E, Berendsen J, Biere A, Bueno D, Ramos V, Aguillón JC, Catalán D. Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation. Front Immunol 2015;6:496. [PMID: 26483788 DOI: 10.3389/fimmu.2015.00496] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
176 Conejo-Garcia JR, Biswas S, Chaurio R. Humoral immune responses: Unsung heroes of the war on cancer. Semin Immunol 2020;49:101419. [PMID: 33183950 DOI: 10.1016/j.smim.2020.101419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Slepicka PF, Yazdanifar M, Bertaina A. Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review. Front Immunol 2021;12:688460. [PMID: 34177941 DOI: 10.3389/fimmu.2021.688460] [Reference Citation Analysis]
178 Medrano M, Carrillo-Cruz E, Montero I, Perez-Simon JA. Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications. Int J Mol Sci 2018;19:E2663. [PMID: 30205552 DOI: 10.3390/ijms19092663] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 17.3] [Reference Citation Analysis]
179 Stohl W. Future prospects in biologic therapy for systemic lupus erythematosus. Nat Rev Rheumatol 2013;9:705-20. [PMID: 24018550 DOI: 10.1038/nrrheum.2013.136] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
180 Tsubata T. Inhibitory B cell co-receptors and autoimmune diseases. Immunological Medicine 2019;42:108-16. [DOI: 10.1080/25785826.2019.1660038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
181 Nikolajczyk BS. B cells as under-appreciated mediators of non-auto-immune inflammatory disease. Cytokine 2010;50:234-42. [PMID: 20382544 DOI: 10.1016/j.cyto.2010.02.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
182 Cencioni MT, Ali R, Nicholas R, Muraro PA. Defective CD19+CD24 hi CD38 hi transitional B-cell function in patients with relapsing-remitting MS. Mult Scler 2021;27:1187-97. [DOI: 10.1177/1352458520951536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
183 Han J, Sun L, Wang Z, Fan X, Wang L, Song YY, Zhu J, Jin T. Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders. Neurol Sci 2017;38:1205-12. [PMID: 28389940 DOI: 10.1007/s10072-017-2932-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
184 Tebbe B, Wilde B, Ye Z, Wang J, Wang X, Jian F, Dolff S, Schedlowski M, Hoyer PF, Kribben A, Witzke O, Hoerning A. Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19+CD24hiCD38hi Regulatory B-Lymphocytes. PLoS One 2016;11:e0153170. [PMID: 27045291 DOI: 10.1371/journal.pone.0153170] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
185 Dörner T, Lipsky PE. Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. Nat Rev Rheumatol 2016;12:645-57. [PMID: 27733759 DOI: 10.1038/nrrheum.2016.158] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
186 Mielle J, Tison A, Cornec D, Le Pottier L, Daien C, Pers JO. B cells in Sjögren's syndrome: from pathophysiology to therapeutic target. Rheumatology (Oxford) 2019:key332. [PMID: 30770916 DOI: 10.1093/rheumatology/key332] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
187 Meinl E, Derfuss T, Krumbholz M, Pröbstel AK, Hohlfeld R. Humoral autoimmunity in multiple sclerosis. J Neurol Sci 2011;306:180-2. [PMID: 20817206 DOI: 10.1016/j.jns.2010.08.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
188 Dong Z, Liu Z, Dai H, Liu W, Feng Z, Zhao Q, Gao Y, Liu F, Zhang N, Dong X, Zhou X, Du J, Huang G, Tian X, Liu B. The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy. J Immunol Res 2020;2020:7638365. [PMID: 33426094 DOI: 10.1155/2020/7638365] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
189 Bigot J, Pilon C, Matignon M, Grondin C, Leibler C, Aissat A, Pirenne F, Cohen JL, Grimbert P. Transcriptomic Signature of the CD24 hi CD38 hi Transitional B Cells Associated With an Immunoregulatory Phenotype in Renal Transplant Recipients. Am J Transplant 2016;16:3430-42. [DOI: 10.1111/ajt.13904] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
190 Zahran AM, Youssef MAM, Shafik EA, Zahran ZAM, El-Badawy O, Abo Elgheet AM, Elsayh KI. Downregulation of B regulatory cells and upregulation of T helper 1 cells in children with Gaucher disease undergoing enzyme replacement therapy. Immunol Res 2020;68:73-80. [PMID: 32524332 DOI: 10.1007/s12026-020-09129-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 Hoffman W, Lakkis FG, Chalasani G. B Cells, Antibodies, and More. Clin J Am Soc Nephrol 2016;11:137-54. [PMID: 26700440 DOI: 10.2215/CJN.09430915] [Cited by in Crossref: 158] [Cited by in F6Publishing: 73] [Article Influence: 26.3] [Reference Citation Analysis]
192 Powell WE, Hanna SJ, Hocter CN, Robinson E, Davies J, Dunseath GJ, Luzio S, Farewell D, Wen L, Dayan CM, Price DA, Ladell K, Wong FS. Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes. Diabetologia 2018;61:1794-803. [PMID: 29881878 DOI: 10.1007/s00125-018-4651-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
193 Xiang W, Xie C, Guan Y. The identification, development and therapeutic potential of IL-10-producing regulatory B cells in multiple sclerosis. J Neuroimmunol 2021;354:577520. [PMID: 33684831 DOI: 10.1016/j.jneuroim.2021.577520] [Reference Citation Analysis]
194 Vadasz Z, Haj T, Kessel A, Toubi E. B-regulatory cells in autoimmunity and immune mediated inflammation. FEBS Lett. 2013;587:2074-2078. [PMID: 23707422 DOI: 10.1016/j.febslet.2013.05.023] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
195 Achour A, Simon Q, Mohr A, Séité J, Youinou P, Bendaoud B, Ghedira I, Pers J, Jamin C. Human regulatory B cells control the T FH cell response. Journal of Allergy and Clinical Immunology 2017;140:215-22. [DOI: 10.1016/j.jaci.2016.09.042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
196 Rosser EC, Blair PA, Mauri C. Cellular targets of regulatory B cell-mediated suppression. Mol Immunol 2014;62:296-304. [PMID: 24556109 DOI: 10.1016/j.molimm.2014.01.014] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
197 Li X, Wang L, Zhou L, ZhangBao J, Miao MZ, Lu C, Lu J, Quan C. The imbalance between regulatory and memory B cells accompanied by an increased number of circulating T-follicular helper cells in MOG-antibody-associated demyelination. Mult Scler Relat Disord 2019;36:101397. [PMID: 31546225 DOI: 10.1016/j.msard.2019.101397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
198 Kamburova EG, Koenen HJPM, Borgman KJE, ten Berge IJ, Joosten I, Hilbrands LB. A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function: Rituximab Alters B Cells in Human Lymph Nodes. American Journal of Transplantation 2013;13:1503-11. [DOI: 10.1111/ajt.12220] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 9.8] [Reference Citation Analysis]
199 Heine G, Drozdenko G, Grün JR, Chang H, Radbruch A, Worm M. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts: Cellular immune response. Eur J Immunol 2014;44:1615-21. [DOI: 10.1002/eji.201343822] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
200 Buffa S, Bulati M, Pellicanò M, Dunn-Walters DK, Wu YC, Candore G, Vitello S, Caruso C, Colonna-Romano G. B cell immunosenescence: different features of naive and memory B cells in elderly. Biogerontology 2011;12:473-83. [PMID: 21879287 DOI: 10.1007/s10522-011-9353-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
201 Karakasheva TA, Dominguez GA, Hashimoto A, Lin EW, Chiu C, Sasser K, Lee JW, Beatty GL, Gabrilovich DI, Rustgi AK. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. JCI Insight 2018;3:97022. [PMID: 29563330 DOI: 10.1172/jci.insight.97022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 11.0] [Reference Citation Analysis]
202 Garcia-Rodriguez S, Callejas-Rubio JL, Ortego-Centeno N, Zumaquero E, Ríos-Fernandez R, Arias-Santiago S, Navarro P, Sancho J, Zubiaur M. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients. Mediators Inflamm 2012;2012:495934. [PMID: 23125486 DOI: 10.1155/2012/495934] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
203 Kluger MA, Ostmann A, Luig M, Meyer MC, Goerke B, Paust HJ, Meyer-Schwesinger C, Stahl RA, Panzer U, Tiegs G, Steinmetz OM. B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis. Eur J Immunol 2014;44:683-93. [PMID: 24227595 DOI: 10.1002/eji.201343842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
204 Luk F, Carreras-Planella L, Korevaar SS, de Witte SFH, Borràs FE, Betjes MGH, Baan CC, Hoogduijn MJ, Franquesa M. Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function. Front Immunol 2017;8:1042. [PMID: 28894451 DOI: 10.3389/fimmu.2017.01042] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 14.5] [Reference Citation Analysis]
205 Palma P, Rinaldi S, Cotugno N, Santilli V, Pahwa S, Rossi P, Cagigi A. Premature B-cell senescence as a consequence of chronic immune activation. Hum Vaccin Immunother 2014;10:2083-8. [PMID: 25424820 DOI: 10.4161/hv.28698] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
206 Zhao Q, Jung LK. Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study. Pediatr Rheumatol Online J 2018;16:44. [PMID: 29973221 DOI: 10.1186/s12969-018-0262-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
207 Goules AV, Kapsogeorgou EK, Tzioufas AG. Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells. Clin Immunol 2017;182:30-40. [PMID: 28330683 DOI: 10.1016/j.clim.2017.03.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
208 Wang X, Zhu Y, Zhang M, Wang H, Jiang Y, Gao P. Ulcerative Colitis Is Characterized by a Decrease in Regulatory B Cells. J Crohns Colitis 2016;10:1212-23. [PMID: 26980839 DOI: 10.1093/ecco-jcc/jjw074] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
209 Vossenkämper A, Lutalo PM, Spencer J. Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol 2012;167:7-14. [PMID: 22132879 DOI: 10.1111/j.1365-2249.2011.04460.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
210 Mok CC. Current role of rituximab in systemic lupus erythematosus. Int J Rheum Dis 2015;18:154-63. [DOI: 10.1111/1756-185x.12463] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
211 Burns M, Ostendorf L, Biesen R, Grützkau A, Hiepe F, Mei HE, Alexander T. Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE. Int J Mol Sci 2021;22:2424. [PMID: 33670902 DOI: 10.3390/ijms22052424] [Reference Citation Analysis]
212 Baba Y, Matsumoto M, Kurosaki T. Signals controlling the development and activity of regulatory B-lineage cells. Int Immunol. 2015;27:487-493. [PMID: 25957265 DOI: 10.1093/intimm/dxv027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
213 Ma L, Liu B, Jiang Z, Jiang Y. Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Rheumatol 2014;33:187-95. [DOI: 10.1007/s10067-013-2359-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
214 DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA. 2013;110:5133-5138. [PMID: 23479618 DOI: 10.1073/pnas.1215840110] [Cited by in Crossref: 281] [Cited by in F6Publishing: 259] [Article Influence: 35.1] [Reference Citation Analysis]
215 Jones AP, Kermode AG, Lucas RM, Carroll WM, Nolan D, Hart PH. Circulating immune cells in multiple sclerosis. Clin Exp Immunol 2017;187:193-203. [PMID: 27689339 DOI: 10.1111/cei.12878] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
216 Ye L, Zhang Q, Cheng Y, Chen X, Wang G, Shi M, Zhang T, Cao Y, Pan H, Zhang L, Wang G, Deng Y, Yang Y, Chen G. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion. J Immunother Cancer 2018;6:145. [PMID: 30526680 DOI: 10.1186/s40425-018-0451-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 19.0] [Reference Citation Analysis]
217 Pavón EJ, Zumaquero E, Rosal-Vela A, Khoo KM, Cerezo-Wallis D, García-Rodríguez S, Carrascal M, Abian J, Graeff R, Callejas-Rubio JL, Ortego-Centeno N, Malavasi F, Zubiaur M, Sancho J. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Cytokine 2013;62:232-43. [PMID: 23538292 DOI: 10.1016/j.cyto.2013.02.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
218 Burbano YCB, Paz AVC, Caldon CCR, Constain JSR, Gonzáles GIÁ, Hernández JCK, Marin-Agudelo N, Dueñas-Cuellar RA, Castaño VEN. Low Frequency Of Regulatory B-Cells And Increased CD4+ and CD8+ Interferon-γ-producing cells in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type. Rev Soc Bras Med Trop 2019;52:e20190101. [PMID: 31340370 DOI: 10.1590/0037-8682-0101-2019] [Reference Citation Analysis]
219 Mckenzie CGJ, Guo L, Freedman J, Semple JW. Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol 2013;163:10-23. [DOI: 10.1111/bjh.12480] [Cited by in Crossref: 109] [Cited by in F6Publishing: 93] [Article Influence: 13.6] [Reference Citation Analysis]
220 Giltiay NV, Shu GL, Shock A, Clark EA. Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling. Arthritis Res Ther 2017;19:91. [PMID: 28506291 DOI: 10.1186/s13075-017-1284-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
221 Morva A, Lemoine S, Achour A, Pers JO, Youinou P, Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012;119:106-14. [PMID: 22067387 DOI: 10.1182/blood-2011-06-360768] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
222 Trend S, Jones AP, Geldenhuys S, Byrne SN, Fabis-Pedrini MJ, Nolan D, Booth DR, Carroll WM, Lucas RM, Kermode AG, Hart PH. Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI. Int J Mol Sci 2017;18:E1277. [PMID: 28617321 DOI: 10.3390/ijms18061277] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
223 Stolp J, Turka LA, Wood KJ. B cells with immune-regulating function in transplantation. Nat Rev Nephrol. 2014;10:389-397. [PMID: 24846332 DOI: 10.1038/nrneph.2014.80] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
224 Land J, Rutgers A, Kallenberg CG. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody. Nephrol Dial Transplant 2014;29:739-45. [PMID: 24398891 DOI: 10.1093/ndt/gft416] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
225 Vasileiadis GK, Dardiotis E, Mavropoulos A, Tsouris Z, Tsimourtou V, Bogdanos DP, Sakkas LI, Hadjigeorgiou GM. Regulatory B and T lymphocytes in multiple sclerosis: friends or foes? Auto Immun Highlights 2018;9:9. [PMID: 30415321 DOI: 10.1007/s13317-018-0109-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
226 Schaut RG, Lamb IM, Toepp AJ, Scott B, Mendes-Aguiar CO, Coutinho JF, Jeronimo SM, Wilson ME, Harty JT, Waldschmidt TJ, Petersen CA. Regulatory IgDhi B Cells Suppress T Cell Function via IL-10 and PD-L1 during Progressive Visceral Leishmaniasis. J Immunol 2016;196:4100-9. [PMID: 27076677 DOI: 10.4049/jimmunol.1502678] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
227 Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca2+ increase and its sensor molecules, STIM1 and STIM2. Mol Immunol 2014;62:339-43. [PMID: 24246800 DOI: 10.1016/j.molimm.2013.10.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
228 Nova-Lamperti E, Fanelli G, Becker PD, Chana P, Elgueta R, Dodd PC, Lord GM, Lombardi G, Hernandez-Fuentes MP. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses. Sci Rep 2016;6:20044. [PMID: 26795594 DOI: 10.1038/srep20044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 10.4] [Reference Citation Analysis]
229 Yanaba K, Kamata M, Ishiura N, Shibata S, Asano Y, Tada Y, Sugaya M, Kadono T, Tedder TF, Sato S. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J Leukoc Biol 2013;94:563-73. [PMID: 23630391 DOI: 10.1189/jlb.1112562] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
230 Bézie S, Picarda E, Ossart J, Martinet B, Anegon I, Guillonneau C. Compensatory Regulatory Networks between CD8 T, B, and Myeloid Cells in Organ Transplantation Tolerance. J Immunol 2015;195:5805-15. [PMID: 26553075 DOI: 10.4049/jimmunol.1500473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
231 Wu H, Xia L, Jia D, Zou H, Jin G, Qian W, Xu H, Li T. PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis. Mol Immunol 2020;119:83-91. [PMID: 32001420 DOI: 10.1016/j.molimm.2020.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
232 Toapanta FR, Bernal PJ, Fresnay S, Magder LS, Darton TC, Jones C, Waddington CS, Blohmke CJ, Angus B, Levine MM, Pollard AJ, Sztein MB. Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease. PLoS Negl Trop Dis 2016;10:e0004766. [PMID: 27300136 DOI: 10.1371/journal.pntd.0004766] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
233 Li H, Wang C, Zhang M, Li X, Zhang P, Yue L, Miao S, Wang S, Liu Y, Li Y, Duan R. Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis. Molecular and Cellular Neuroscience 2015;68:284-92. [DOI: 10.1016/j.mcn.2015.08.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
234 Liu J, Zhan W, Kim CJ, Clayton K, Zhao H, Lee E, Cao JC, Ziegler B, Gregor A, Yue FY, Huibner S, MacParland S, Schwartz J, Song HH, Benko E, Gyenes G, Kovacs C, Kaul R, Ostrowski M. IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses. PLoS One 2014;9:e89236. [PMID: 24586620 DOI: 10.1371/journal.pone.0089236] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
235 Fremd C, Schuetz F, Sohn C, Beckhove P, Domschke C. B cell-regulated immune responses in tumor models and cancer patients. Oncoimmunology 2013;2:e25443. [PMID: 24073382 DOI: 10.4161/onci.25443] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 11.4] [Reference Citation Analysis]
236 Zhu Q, Rui K, Wang S, Tian J. Advances of Regulatory B Cells in Autoimmune Diseases. Front Immunol 2021;12:592914. [PMID: 33936028 DOI: 10.3389/fimmu.2021.592914] [Reference Citation Analysis]
237 Morris-Rosenfeld S, Lipinski MJ, McNamara CA. Understanding the role of B cells in atherosclerosis: potential clinical implications. Expert Rev Clin Immunol 2014;10:77-89. [PMID: 24308836 DOI: 10.1586/1744666X.2014.857602] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
238 Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O, Laman JD, Grinyó JM, Weimar W. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells. 2015;33:880-891. [PMID: 25376628 DOI: 10.1002/stem.1881] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 17.7] [Reference Citation Analysis]
239 Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11:34-46. [PMID: 21151033 DOI: 10.1038/nri2901] [Cited by in Crossref: 598] [Cited by in F6Publishing: 523] [Article Influence: 54.4] [Reference Citation Analysis]
240 Agrawal S, Gupta S. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J Clin Immunol 2011;31:89-98. [PMID: 20821041 DOI: 10.1007/s10875-010-9456-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
241 Mirlekar B, Michaud D, Lee SJ, Kren NP, Harris C, Greene K, Goldman EC, Gupta GP, Fields RC, Hawkins WG, DeNardo DG, Rashid NU, Yeh JJ, McRee AJ, Vincent BG, Vignali DAA, Pylayeva-Gupta Y. B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer. Cancer Immunol Res 2020;8:292-308. [PMID: 32024640 DOI: 10.1158/2326-6066.CIR-19-0349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
242 Doyon-Laliberté K, Chagnon-Choquet J, Byrns M, Aranguren M, Memmi M, Chrobak P, Stagg J, Poudrier J, Roger M. NR4A Expression by Human Marginal Zone B-Cells. Antibodies (Basel) 2019;8:E50. [PMID: 31614541 DOI: 10.3390/antib8040050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Srivastava A, Makarenkova HP. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome. Int J Mol Sci 2020;21:E9172. [PMID: 33271951 DOI: 10.3390/ijms21239172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
244 Bulati M, Caruso C, Colonna-Romano G. From lymphopoiesis to plasma cells differentiation, the age-related modifications of B cell compartment are influenced by "inflamm-ageing". Ageing Res Rev 2017;36:125-36. [PMID: 28396185 DOI: 10.1016/j.arr.2017.04.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
245 Singh RP, Hahn BH, Bischoff DS. Effects of Peptide-Induced Immune Tolerance on Murine Lupus. Front Immunol 2021;12:662901. [PMID: 34093553 DOI: 10.3389/fimmu.2021.662901] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Biragyn A, Longo DL. Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses. Semin Cancer Biol 2012;22:50-9. [PMID: 22257681 DOI: 10.1016/j.semcancer.2012.01.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
247 Zu J, Yao L, Song Y, Cui Y, Guan M, Chen R, Zhen Y, Li S. Th2 Biased Immunity With Altered B Cell Profiles in Circulation of Patients With Sporotrichosis Caused by Sporothrix globosa. Front Immunol 2020;11:570888. [PMID: 33281813 DOI: 10.3389/fimmu.2020.570888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Ben ERRD, Prado CHD, Baptista TSA, Bauer ME, Staub HL. Pacientes com lúpus eritematoso sistêmico e síndrome antifosfolípide secundária possuem números reduzidos de células B CD4+ CD25+ Foxp3+ (células Treg) e células B CD3– CD19+ circulantes. Revista Brasileira de Reumatologia 2014;54:241-6. [DOI: 10.1016/j.rbr.2013.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
249 Miyazaki Y, Niino M. Molecular targeted therapy against B cells in multiple sclerosis. Clin Exp Neuroimmunol 2014;5:16-27. [DOI: 10.1111/cen3.12160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
250 Boulassel MR, Al-Ghonimi M, Al-Balushi B, Al-Naamani A, Al-Qarni Z, Wali Y, Elshinawy M, Al-Shezawi M, Khan H, Nazir H, Khater D, Pathare A, Al-Kindi S. Regulatory B Cells Are Functionally Impaired in Patients Having Hemophilia A With Inhibitors. Clin Appl Thromb Hemost 2018;24:618-24. [PMID: 28393618 DOI: 10.1177/1076029617702244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
251 Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L, Krishfield S, Malavasi F, Yoon J, Sui SJH, Kyttaris VC, Tsokos GC. The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections. Cell Rep 2020;30:112-123.e4. [PMID: 31914379 DOI: 10.1016/j.celrep.2019.12.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 43.0] [Reference Citation Analysis]
252 Kim Y, Kim G, Shin HJ, Hyun JW, Kim SH, Lee E, Kim HJ. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis. J Neuroinflammation 2018;15:300. [PMID: 30373595 DOI: 10.1186/s12974-018-1334-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
253 Salinas GF, Braza F, Brouard S, Tak PP, Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin Immunol 2013;146:34-45. [PMID: 23202542 DOI: 10.1016/j.clim.2012.10.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
254 Mei HE, Schmidt S, Dörner T. Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity. Arthritis Res Ther 2012;14 Suppl 5:S1. [PMID: 23281743 DOI: 10.1186/ar3909] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 6.2] [Reference Citation Analysis]
255 Jones AP, Trend S, Byrne SN, Fabis-Pedrini MJ, Geldenhuys S, Nolan D, Booth DR, Carroll WM, Lucas RM, Kermode AG, Hart PH. Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis. Clin Transl Immunology 2017;6:e143. [PMID: 28690849 DOI: 10.1038/cti.2017.18] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
256 Zhao H, Feng R, Peng A, Li G, Zhou L. The expanding family of noncanonical regulatory cell subsets. J Leukoc Biol 2019;106:369-83. [DOI: 10.1002/jlb.6ru0918-353rrrr] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
257 Gatto M, Zen M, Ghirardello A, Bettio S, Bassi N, Iaccarino L, Punzi L, Doria A. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013;12:523-36. [PMID: 23000207 DOI: 10.1016/j.autrev.2012.09.003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
258 Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Ashida K, Sakabe T, Nakayama Y, Fujiwara Y. Increased regulatory B cells are involved in immune evasion in patients with gastric cancer. Sci Rep 2019;9:13083. [PMID: 31511630 DOI: 10.1038/s41598-019-49581-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
259 Monson NL, Ortega SB, Ireland SJ, Meeuwissen AJ, Chen D, Plautz EJ, Shubel E, Kong X, Li MK, Freriks LH, Stowe AM. Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke. J Neuroinflammation 2014;11:22. [PMID: 24485041 DOI: 10.1186/1742-2094-11-22] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
260 Mirlekar B, Michaud D, Pylayeva-Gupta Y. IL-35 Detection in B Cells at the mRNA and Protein Level. Methods Mol Biol 2021;2270:125-47. [PMID: 33479897 DOI: 10.1007/978-1-0716-1237-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Girard MC, Acevedo GR, Ossowski MS, Fernández M, Hernández Y, Chadi R, Gómez KA. Ex vivo characterization of Breg cells in patients with chronic Chagas disease. Sci Rep 2021;11:5511. [PMID: 33750870 DOI: 10.1038/s41598-021-84765-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Tedder TF. B10 cells: a functionally defined regulatory B cell subset. J Immunol. 2015;194:1395-1401. [PMID: 25663677 DOI: 10.4049/jimmunol.1401329] [Cited by in Crossref: 178] [Cited by in F6Publishing: 165] [Article Influence: 29.7] [Reference Citation Analysis]
263 Azevedo PC, Murphy G, Isenberg DA. Pathology of systemic lupus erythematosus: the challenges ahead. Methods Mol Biol 2014;1134:1-16. [PMID: 24497350 DOI: 10.1007/978-1-4939-0326-9_1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
264 Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S, Fan B, O'Connor RA, Anderton SM, Bar-Or A, Fillatreau S, Gray D. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012;209:1001-10. [PMID: 22547654 DOI: 10.1084/jem.20111675] [Cited by in Crossref: 389] [Cited by in F6Publishing: 350] [Article Influence: 43.2] [Reference Citation Analysis]
265 Gu Y, Li K, Sun J, Zhang J. Characterization of CD19+ CD24hi CD38hi B cells in Chinese adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2020;34:2863-70. [PMID: 32242984 DOI: 10.1111/jdv.16399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Turka LA, Wood K, Bluestone JA. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia. Curr Opin Organ Transplant 2010;15:441-8. [PMID: 20631613 DOI: 10.1097/MOT.0b013e32833bd371] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
267 Smits HH. B cells in allergic diseases: Bad or Better? Autoimmunity 2012;45:415-26. [DOI: 10.3109/08916934.2012.665525] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
268 Santaguida MG, Gatto I, Mangino G, Virili C, Stramazzo I, Fallahi P, Antonelli A, Segni M, Romeo G, Centanni M. BREG cells in Hashimoto's thyroiditis isolated or associated to further organ-specific autoimmune diseases. Clinical Immunology 2017;184:42-7. [DOI: 10.1016/j.clim.2017.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
269 Hasan MM, Nair SS, O'Leary JG, Thompson-Snipes L, Nyarige V, Wang J, Park W, Stegall M, Heilman R, Klintmalm GB, Joo H, Oh S. Implication of TIGIT+ human memory B cells in immune regulation. Nat Commun 2021;12:1534. [PMID: 33750787 DOI: 10.1038/s41467-021-21413-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
270 Hu S, Chen M, Wang Y, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. PLoS One 2016;11:e0154564. [PMID: 27128484 DOI: 10.1371/journal.pone.0154564] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
271 Sanaei MJ, Nahid-Samiei M, Abadi MSS, Arjmand MH, Ferns GA, Bashash D, Rahimian G, Bagheri N. New insights into regulatory B cells biology in viral, bacterial, and parasitic infections. Infect Genet Evol 2021;89:104753. [PMID: 33545392 DOI: 10.1016/j.meegid.2021.104753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
272 Kieler M, Unseld M, Bianconi D, Prager G. Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity Cycle. Pancreas. 2018;47:142-157. [PMID: 29346215 DOI: 10.1097/mpa.0000000000000970] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
273 Choi JK, Egwuagu CE. Interleukin 35 Regulatory B Cells. J Mol Biol 2021;433:166607. [PMID: 32755620 DOI: 10.1016/j.jmb.2020.07.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
274 Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia. 2010;53:1461-1471. [PMID: 20383694 DOI: 10.1007/s00125-010-1730-z] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 9.7] [Reference Citation Analysis]
275 Ma K, Du W, Wang X, Yuan S, Cai X, Liu D, Li J, Lu L. Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus. Int J Mol Sci 2019;20:E6021. [PMID: 31795353 DOI: 10.3390/ijms20236021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
276 Aguilar-Jimenez W, Villegas-Ospina S, Gonzalez S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr 2016;73:497-506. [PMID: 27509245 DOI: 10.1097/QAI.0000000000001150] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
277 Tormo A, Deng J, Al-chami E, Ziouani S, Rafei M. Ex Vivo Generation of Murine IL-10-Producing B Cells by Fusokines. In: Vitale G, Mion F, editors. Regulatory B Cells. New York: Springer; 2014. pp. 115-25. [DOI: 10.1007/978-1-4939-1161-5_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
278 Lu J, Ding Y, Yi X, Zheng J. CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity. Braz J Med Biol Res 2016;49:e5374. [PMID: 27532281 DOI: 10.1590/1414-431X20165374] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
279 Matsushita T. Regulatory B cells in mouse models of systemic lupus erythematosus (SLE). Methods Mol Biol 2014;1190:195-205. [PMID: 25015282 DOI: 10.1007/978-1-4939-1161-5_14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
280 Nouël A, Simon Q, Jamin C, Pers JO, Hillion S. Regulatory B cells: an exciting target for future therapeutics in transplantation. Front Immunol 2014;5:11. [PMID: 24478776 DOI: 10.3389/fimmu.2014.00011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
281 Guzman-Genuino RM, Diener KR. Regulatory B Cells in Pregnancy: Lessons from Autoimmunity, Graft Tolerance, and Cancer. Front Immunol 2017;8:172. [PMID: 28261223 DOI: 10.3389/fimmu.2017.00172] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
282 Zarkhin V, Sarwal MM. The coin toss of B cells in rejection and tolerance: danger versus defense. Semin Immunol 2012;24:86-91. [PMID: 22035649 DOI: 10.1016/j.smim.2011.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
283 De S, Barnes BJ. B cell transcription factors: Potential new therapeutic targets for SLE. Clinical Immunology 2014;152:140-51. [DOI: 10.1016/j.clim.2014.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
284 Taher TE, Ong VH, Bystrom J, Hillion S, Simon Q, Denton CP, Pers JO, Abraham DJ, Mageed RA. Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis. Arthritis Rheumatol 2018;70:450-61. [PMID: 29193892 DOI: 10.1002/art.40390] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
285 Mion F, Tonon S, Toffoletto B, Cesselli D, Pucillo CE, Vitale G. IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation. Molecular Immunology 2014;62:266-76. [DOI: 10.1016/j.molimm.2014.05.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
286 Laksono BM, de Vries RD, Verburgh RJ, Visser EG, de Jong A, Fraaij PLA, Ruijs WLM, Nieuwenhuijse DF, van den Ham HJ, Koopmans MPG, van Zelm MC, Osterhaus ADME, de Swart RL. Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nat Commun 2018;9:4944. [PMID: 30470742 DOI: 10.1038/s41467-018-07515-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 14.3] [Reference Citation Analysis]
287 Schubert RD, Hu Y, Kumar G, Szeto S, Abraham P, Winderl J, Guthridge JM, Pardo G, Dunn J, Steinman L, Axtell RC. IFN-β treatment requires B cells for efficacy in neuroautoimmunity. J Immunol 2015;194:2110-6. [PMID: 25646307 DOI: 10.4049/jimmunol.1402029] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
288 Wang X, Li J, Lu C, Wang G, Wang Z, Liu X, Liu B, Wang G, Zhang Q, Yang Q. IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation. Experimental Cell Research 2019;376:192-7. [DOI: 10.1016/j.yexcr.2019.01.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
289 Leibler C, Matignon M, Pilon C, Montespan F, Bigot J, Lang P, Carosella ED, Cohen J, Rouas-Freiss N, Grimbert P, Menier C. Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells. Am J Transplant 2014;14:1173-82. [PMID: 24730563 DOI: 10.1111/ajt.12721] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
290 Banham GD, Clatworthy MR. B-cell biomarkers in transplantation - from genes to therapy: B-cell biomarkers in transplantation. Tissue Antigens 2015;85:82-92. [DOI: 10.1111/tan.12520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
291 Sarmiento Varon L, De Rosa J, Machicote A, Billordo LA, Baz P, Fernández PM, Kaimen Maciel I, Blanco A, Arana EI. Characterization of tonsillar IL10 secreting B cells and their role in the pathophysiology of tonsillar hypertrophy. Sci Rep 2017;7:11077. [PMID: 28894116 DOI: 10.1038/s41598-017-09689-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
292 Zhang H, Yue R, Zhao P, Yu X, Li J, Ma G, Tang J, Zhang L, Feng L, Sun L, Song Z, Guo C, Wang N. Proinflammatory follicular helper T cells promote immunoglobulin G secretion, suppress regulatory B cell development, and correlate with worse clinical outcomes in gastric cancer. Tumour Biol 2017;39:1010428317705747. [PMID: 28631561 DOI: 10.1177/1010428317705747] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
293 Wiest M, Upchurch K, Hasan MM, Cardenas J, Lanier B, Millard M, Turner J, Oh S, Joo H. Phenotypic and functional alterations of regulatory B cell subsets in adult allergic asthma patients. Clin Exp Allergy 2019;49:1214-24. [PMID: 31132180 DOI: 10.1111/cea.13439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
294 Wang T, Marken J, Chen J, Tran VB, Li QZ, Li M, Cerosaletti K, Elkon KB, Zeng X, Giltiay NV. High TLR7 Expression Drives the Expansion of CD19+CD24hiCD38hi Transitional B Cells and Autoantibody Production in SLE Patients. Front Immunol 2019;10:1243. [PMID: 31231380 DOI: 10.3389/fimmu.2019.01243] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
295 Nakken B, Munthe LA, Konttinen YT, Sandberg AK, Szekanecz Z, Alex P, Szodoray P. B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives. Autoimmunity Reviews 2011;11:28-34. [DOI: 10.1016/j.autrev.2011.06.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
296 Sarvaria A, Madrigal JA, Saudemont A. B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 2017;14:662-74. [PMID: 28626234 DOI: 10.1038/cmi.2017.35] [Cited by in Crossref: 201] [Cited by in F6Publishing: 182] [Article Influence: 50.3] [Reference Citation Analysis]
297 Boldison J, Da Rosa LC, Davies J, Wen L, Wong FS. Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells. Cell Mol Immunol 2020;17:843-55. [PMID: 31728048 DOI: 10.1038/s41423-019-0324-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
298 Chen Q, Lai L, Chi X, Lu X, Wu H, Sun J, Wu W, Cai L, Zeng X, Wang C, Chen W, Peng A. CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis. Mediators Inflamm 2020;2020:3019378. [PMID: 32104147 DOI: 10.1155/2020/3019378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
299 Zeng SG, Ghnewa YG, O'Reilly VP, Lyons VG, Atzberger A, Hogan AE, Exley MA, Doherty DG. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro. J Immunol 2013;191:1666-76. [PMID: 23851681 DOI: 10.4049/jimmunol.1202223] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
300 Esteve-Solé A, Luo Y, Vlagea A, Deyà-Martínez Á, Yagüe J, Plaza-Martín AM, Juan M, Alsina L. B Regulatory Cells: Players in Pregnancy and Early Life. Int J Mol Sci 2018;19:E2099. [PMID: 30029515 DOI: 10.3390/ijms19072099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
301 Heinemann K, Wilde B, Hoerning A, Tebbe B, Kribben A, Witzke O, Dolff S. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients. Scand J Rheumatol 2016;45:312-6. [PMID: 26948375 DOI: 10.3109/03009742.2015.1126346] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
302 Garg K, Maurer M, Griss J, Brüggen M, Wolf IH, Wagner C, Willi N, Mertz KD, Wagner SN. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome. Human Pathology 2016;54:157-64. [DOI: 10.1016/j.humpath.2016.03.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 10.6] [Reference Citation Analysis]
303 Cardoso CC, Santos-silva MC. Eight-color panel for immune phenotype monitoring by flow cytometry. Journal of Immunological Methods 2019;468:40-8. [DOI: 10.1016/j.jim.2019.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
304 Menon M, Blair PA, Isenberg DA, Mauri C. A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus. Immunity 2016;44:683-97. [PMID: 26968426 DOI: 10.1016/j.immuni.2016.02.012] [Cited by in Crossref: 172] [Cited by in F6Publishing: 158] [Article Influence: 34.4] [Reference Citation Analysis]
305 Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët JF, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity 2017;46:301-14. [PMID: 28228284 DOI: 10.1016/j.immuni.2017.01.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 15.5] [Reference Citation Analysis]
306 Li X, Gao Q, Feng Y, Zhang X. Developing role of B cells in the pathogenesis and treatment of chronic GVHD. Br J Haematol. 2019;184:323-336. [PMID: 30585319 DOI: 10.1111/bjh.15719] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
307 Gleeson M, Bishop N, Oliveira M, Tauler P. Influence of training load on upper respiratory tract infection incidence and antigen-stimulated cytokine production. Scand J Med Sci Sports 2013;23:451-7. [PMID: 22151281 DOI: 10.1111/j.1600-0838.2011.01422.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
308 Villegas-Ospina S, Aguilar-Jimenez W, Gonzalez SM, Rugeles MT. Vitamin D modulates the expression of HLA-DR and CD38 after in vitro activation of T-cells. Horm Mol Biol Clin Investig 2017;29:93-103. [PMID: 28222027 DOI: 10.1515/hmbci-2016-0037] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
309 de Masson A, Bouaziz JD, Le Buanec H, Robin M, O’Meara A, Parquet N, Rybojad M, Hau E, Monfort JB, Branchtein M. CD24(hi)CD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-1839. [PMID: 25605369 DOI: 10.1182/blood-2014-09-599159] [Cited by in Crossref: 98] [Cited by in F6Publishing: 100] [Article Influence: 16.3] [Reference Citation Analysis]
310 Maddur MS, Sharma M, Hegde P, Stephen-Victor E, Pulendran B, Kaveri SV, Bayry J. Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand. Nat Commun 2014;5:4092. [PMID: 24910129 DOI: 10.1038/ncomms5092] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
311 Figueiró F, Muller L, Funk S, Jackson EK, Battastini AM, Whiteside TL. Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). Oncoimmunology 2016;5:e1082703. [PMID: 27057473 DOI: 10.1080/2162402X.2015.1082703] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 11.4] [Reference Citation Analysis]
312 Willsmore ZN, Harris RJ, Crescioli S, Hussein K, Kakkassery H, Thapa D, Cheung A, Chauhan J, Bax HJ, Chenoweth A, Laddach R, Osborn G, McCraw A, Hoffmann RM, Nakamura M, Geh JL, MacKenzie-Ross A, Healy C, Tsoka S, Spicer JF, Papa S, Barber L, Lacy KE, Karagiannis SN. B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies. Front Immunol 2020;11:622442. [PMID: 33569063 DOI: 10.3389/fimmu.2020.622442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
313 von Borstel A, Sanders JS, Rutgers A, Stegeman CA, Heeringa P, Abdulahad WH. Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides. Autoimmunity Reviews 2018;17:413-21. [DOI: 10.1016/j.autrev.2017.12.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
314 Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012;18:871-82. [PMID: 22674006 DOI: 10.1038/nm.2752] [Cited by in Crossref: 257] [Cited by in F6Publishing: 225] [Article Influence: 28.6] [Reference Citation Analysis]
315 Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, Smits HH. Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011;128:733-9. [PMID: 21684587 DOI: 10.1016/j.jaci.2011.05.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 8.5] [Reference Citation Analysis]
316 Bao Y, Cao X. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. J Autoimmun 2014;55:10-23. [PMID: 24794622 DOI: 10.1016/j.jaut.2014.04.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 12.1] [Reference Citation Analysis]
317 Alhabbab RY, Nova-lamperti E, Aravena O, Burton HM, Lechler RI, Dorling A, Lombardi G. Regulatory B cells: Development, phenotypes, functions, and role in transplantation. Immunol Rev 2019;292:164-79. [DOI: 10.1111/imr.12800] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
318 Saussine A, Tazi A, Feuillet S, Rybojad M, Juillard C, Bergeron A, Dessirier V, Bouhidel F, Janin A, Bensussan A, Bagot M, Bouaziz JD. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS One 2012;7:e43588. [PMID: 22927996 DOI: 10.1371/journal.pone.0043588] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
319 Wortel CM, Heidt S. Regulatory B cells: Phenotype, function and role in transplantation. Transpl Immunol 2017;41:1-9. [PMID: 28257995 DOI: 10.1016/j.trim.2017.02.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
320 Norouzian M, Mehdipour F, Balouchi Anaraki S, Ashraf MJ, Khademi B, Ghaderi A. Atypical Memory and Regulatory B Cell Subsets in Tumor Draining Lymph Nodes of Head and Neck Squamous Cell Carcinoma Correlate with Good Prognostic Factors. Head Neck Pathol 2020;14:645-56. [PMID: 31691165 DOI: 10.1007/s12105-019-01095-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
321 Heidt S, Hester J, Shankar S, Friend PJ, Wood KJ. B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells. Am J Transplant. 2012;12:1784-1792. [PMID: 22420490 DOI: 10.1111/j.1600-6143.2012.04012.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
322 Chu M, Wong CK, Cai Z, Dong J, Jiao D, Kam NW, Lam CW, Tam LS. Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus. Molecules 2015;20:19588-604. [PMID: 26516833 DOI: 10.3390/molecules201019588] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
323 Méndez-Flores S, Hernández-Molina G, Enríquez AB, Faz-Muñoz D, Esquivel Y, Pacheco-Molina C, Furuzawa-Carballeda J. Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study. Mediators Inflamm 2016;2016:7074829. [PMID: 27041826 DOI: 10.1155/2016/7074829] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
324 Gupte KS, Vanikar AV, Trivedi HL, Patel CN, Patel JV. In-vitro generation of interleukin-10 secreting B-regulatory cells from donor adipose tissue derived mesenchymal stem cells and recipient peripheral blood mononuclear cells for potential cell therapy. Biomed J 2017;40:49-54. [PMID: 28411882 DOI: 10.1016/j.bj.2017.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
325 van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A, Janssen Bonas M, Dijksman TR, Labuda LA, Schot R, Guigas B, Möller GM, Hiemstra PS, Yazdanbakhsh M, Smits HH. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy 2014;44:517-28. [PMID: 24261983 DOI: 10.1111/cea.12238] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
326 Garner-Spitzer E, Wagner A, Paulke-Korinek M, Kollaritsch H, Heinz FX, Redlberger-Fritz M, Stiasny K, Fischer GF, Kundi M, Wiedermann U. Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10. J Immunol 2013;191:2426-36. [PMID: 23872054 DOI: 10.4049/jimmunol.1300293] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
327 Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J; SOLARIUM study group. Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study. J Neuroimmunol 2016;300:47-56. [PMID: 27806875 DOI: 10.1016/j.jneuroim.2016.09.018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 10.4] [Reference Citation Analysis]
328 Graham MT, Nadeau KC. Lessons learned from mice and man: mimicking human allergy through mouse models. Clin Immunol 2014;155:1-16. [PMID: 25131136 DOI: 10.1016/j.clim.2014.08.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
329 Bar-Or A, Steinman L, Behne JM, Benitez-Ribas D, Chin PS, Clare-Salzler M, Healey D, Kim JI, Kranz DM, Lutterotti A, Martin R, Schippling S, Villoslada P, Wei CH, Weiner HL, Zamvil SS, Smith TJ, Yeaman MR. Restoring immune tolerance in neuromyelitis optica: Part II. Neurol Neuroimmunol Neuroinflamm 2016;3:e277. [PMID: 27648464 DOI: 10.1212/NXI.0000000000000277] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
330 Wang H, Liu C, Chen W, Ding G. The skewed frequency of B-cell subpopulation CD19+ CD24 hi CD38 hi cells in peripheral blood mononuclear cells is correlated with the elevated serum sCD40L in patients with active systemic lupus erythematosus. J Cell Biochem 2019. [PMID: 30771230 DOI: 10.1002/jcb.28427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
331 Michel L, Chesneau M, Manceau P, Genty A, Garcia A, Salou M, Elong Ngono A, Pallier A, Jacq-Foucher M, Lefrère F, Wiertlewski S, Soulillou JP, Degauque N, Laplaud DA, Brouard S. Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis. Clin Immunol 2014;155:198-208. [PMID: 25267439 DOI: 10.1016/j.clim.2014.09.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
332 Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP, Biragyn A. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells. Cancer Res 2011;71:3505-15. [PMID: 21444674 DOI: 10.1158/0008-5472.CAN-10-4316] [Cited by in Crossref: 331] [Cited by in F6Publishing: 190] [Article Influence: 33.1] [Reference Citation Analysis]
333 Mizoguchi A, Bhan AK. Immunobiology of B Cells in Inflammatory Bowel Disease. In: Baumgart DC, editor. Crohn's Disease and Ulcerative Colitis. Cham: Springer International Publishing; 2017. pp. 111-7. [DOI: 10.1007/978-3-319-33703-6_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
334 Silva HM, Takenaka MC, Moraes-Vieira PM, Monteiro SM, Hernandez MO, Chaara W, Six A, Agena F, Sesterheim P, Barbé-Tuana FM, Saitovitch D, Lemos F, Kalil J, Coelho V. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med 2012;18:733-43. [PMID: 22252714 DOI: 10.2119/molmed.2011.00281] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
335 Shiu KY, McLaughlin L, Rebollo-Mesa I, Zhao J, Burton H, Douthwaite H, Wilkinson H, Semik V, Dodd PC, Brookes P, Lechler RI, Hernandez-Fuentes MP, Kemper C, Dorling A. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells. Kidney Int 2017;91:477-92. [PMID: 27988211 DOI: 10.1016/j.kint.2016.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
336 Benner M, Feyaerts D, García CC, Inci N, López SC, Fasse E, Shadmanfar W, van der Heijden OWH, Gorris MAJ, Joosten I, Ferwerda G, van der Molen RG. Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus. Cell Rep 2020;32:108204. [PMID: 32997982 DOI: 10.1016/j.celrep.2020.108204] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
337 Kalampokis I, Venturi GM, Poe JC, Dvergsten JA, Sleasman JW, Tedder TF. The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity. Arthritis Rheumatol 2017;69:225-38. [PMID: 27429419 DOI: 10.1002/art.39820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
338 Grasseau A, Boudigou M, Le Pottier L, Chriti N, Cornec D, Pers JO, Renaudineau Y, Hillion S. Innate B Cells: the Archetype of Protective Immune Cells. Clin Rev Allergy Immunol 2020;58:92-106. [PMID: 31183788 DOI: 10.1007/s12016-019-08748-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
339 Fujimoto M. Regulatory B cells in skin and connective tissue diseases. Journal of Dermatological Science 2010;60:1-7. [DOI: 10.1016/j.jdermsci.2010.08.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
340 Shang J, Zha H, Sun Y. Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer. Front Immunol 2020;11:582657. [PMID: 33193391 DOI: 10.3389/fimmu.2020.582657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
341 Tedesco M, Gallieni M, Pellegata F, Cozzolino M, Alberici F. Update on ANCA-associated vasculitis: from biomarkers to therapy. J Nephrol 2019;32:871-82. [DOI: 10.1007/s40620-019-00628-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
342 Heidt S, Hester J, Shankar S, Friend PJ, Wood KJ. B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells. Am J Transplant. 2012;12:1784-1792. [PMID: 22420490 DOI: 10.1111/j.1600-6143.2012.04 012.x] [Reference Citation Analysis]
343 Parsons RF, Redfield RR 3rd, Rodriguez E, Mustafa MM, Vivek K, Murayama M, Naji A, Noorchashm H. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance. Semin Immunol 2012;24:109-14. [PMID: 21978627 DOI: 10.1016/j.smim.2011.08.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
344 Nielsen CH, Börnsen L, Sellebjerg F, Brimnes MK. Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis. PLoS One 2016;11:e0146971. [PMID: 26756931 DOI: 10.1371/journal.pone.0146971] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
345 Ritter M, Osei-Mensah J, Debrah LB, Kwarteng A, Mubarik Y, Debrah AY, Pfarr K, Hoerauf A, Layland LE. Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment. PLoS Negl Trop Dis 2019;13:e0007436. [PMID: 31120872 DOI: 10.1371/journal.pntd.0007436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
346 Zhang L, Tai YT, Ho M, Xing L, Chauhan D, Gang A, Qiu L, Anderson KC. Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu. Blood Cancer J 2017;7:e547. [PMID: 28338671 DOI: 10.1038/bcj.2017.24] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
347 Min Y, Wang X, Chen H, Yin G. The exploration of Hashimoto's Thyroiditis related miscarriage for better treatment modalities. Int J Med Sci 2020;17:2402-15. [PMID: 33029083 DOI: 10.7150/ijms.48128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous hematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology (Oxford) 2021:keab257. [PMID: 33724344 DOI: 10.1093/rheumatology/keab257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Kim JI, Rothstein DM, Markmann JF. Role of B cells in tolerance induction. Curr Opin Organ Transplant 2015;20:369-75. [PMID: 26107970 DOI: 10.1097/MOT.0000000000000204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
350 Day J, Limaye V, Proudman S, Hayball JD, Hissaria P. The utility of monitoring peripheral blood lymphocyte subsets by flow cytometric analysis in patients with rheumatological diseases treated with rituximab. Autoimmunity Reviews 2017;16:542-7. [DOI: 10.1016/j.autrev.2017.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
351 Habib J, Deng J, Lava N, Tyor W, Galipeau J. Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients. J Mult Scler (Foster City) 2015;2:1000139. [PMID: 26137596 DOI: 10.4172/2376-0389.1000139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
352 Floudas A, Amu S, Fallon PG. New Insights into IL-10 Dependent and IL-10 Independent Mechanisms of Regulatory B Cell Immune Suppression. J Clin Immunol 2016;36:25-33. [DOI: 10.1007/s10875-016-0263-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
353 Ma OK, Chan KH. Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes. World J Stem Cells. 2016;8:268-278. [PMID: 27679683 DOI: 10.4252/wjsc.v8.i9.268] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
354 Langkjær A, Kristensen B, Hansen BE, Schultz H, Hegedüs L, Nielsen CH. B-cell exposure to self-antigen induces IL-10 producing B cells as well as IL-6- and TNF-α-producing B-cell subsets in healthy humans. Clinical Immunology 2012;145:1-10. [DOI: 10.1016/j.clim.2012.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
355 Jhun JY, Kim HY, Byun JK, Chung BH, Bae SH, Yoon SK, Kim DG, Yang CW, Cho M, Choi JY. B-cell–associated immune profiles in patients with decompensated cirrhosis. Scandinavian Journal of Gastroenterology 2015;50:884-91. [DOI: 10.3109/00365521.2014.907335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
356 Zhu JF, Xu Y, Zhao J, Li X, Meng X, Wang TQ, Zou BY, Zhao PY, Liu Q, Lu CL, Zheng FL, Liu HS. IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response. J Immunol Res 2018;2018:1827901. [PMID: 30539029 DOI: 10.1155/2018/1827901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
357 Quan C, Yu H, Qiao J, Xiao B, Zhao G, Wu Z, Li Z, Lu C. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Mult Scler 2013;19:289-98. [PMID: 22864301 DOI: 10.1177/1352458512454771] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
358 Baba Y, Kurosaki T. Role of Calcium Signaling in B Cell Activation and Biology. Curr Top Microbiol Immunol 2016;393:143-74. [PMID: 26369772 DOI: 10.1007/82_2015_477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
359 Abdulahad WH, Kroese FG, Vissink A, Bootsma H. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome. J Autoimmun 2012;39:103-11. [PMID: 22341852 DOI: 10.1016/j.jaut.2012.01.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
360 Giltiay NV, Giordano D, Clark EA. The Plasticity of Newly Formed B Cells. J Immunol 2019;203:3095-104. [PMID: 31818922 DOI: 10.4049/jimmunol.1900928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
361 BitMansour A, Pop LM, Vitetta ES. The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy. PLoS One 2016;11:e0167618. [PMID: 27959896 DOI: 10.1371/journal.pone.0167618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
362 Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission. Journal of Neuroimmunology 2011;239:80-6. [DOI: 10.1016/j.jneuroim.2011.08.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
363 Vincent FB, Morand EF, Mackay F. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol 2012;90:293-303. [PMID: 22231653 DOI: 10.1038/icb.2011.111] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
364 Gutiérrez C, Lopez-Abente J, Pérez-Fernández V, Prieto-Sánchez A, Correa-Rocha R, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M. Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients. PLoS One 2019;14:e0213744. [PMID: 30917149 DOI: 10.1371/journal.pone.0213744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
365 Braza F, Chesne J, Durand M, Dirou S, Brosseau C, Mahay G, Cheminant MA, Magnan A, Brouard S. A regulatory CD9(+) B-cell subset inhibits HDM-induced allergic airway inflammation. Allergy 2015;70:1421-31. [PMID: 26194936 DOI: 10.1111/all.12697] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
366 Zhu S, Wang X, Wang J, Lin J, Cong Y, Qiao G. CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses. Exp Cell Res 2017;361:149-54. [PMID: 29054490 DOI: 10.1016/j.yexcr.2017.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
367 von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS. Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol 2015;73:238-46. [PMID: 25824054 DOI: 10.1159/000377675] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
368 Hofmann K, Clauder AK, Manz RA. Targeting B Cells and Plasma Cells in Autoimmune Diseases. Front Immunol 2018;9:835. [PMID: 29740441 DOI: 10.3389/fimmu.2018.00835] [Cited by in Crossref: 91] [Cited by in F6Publishing: 68] [Article Influence: 30.3] [Reference Citation Analysis]
369 van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Söllner S, Akdis DG, Rückert B, Akdis CA, Akdis M. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131:1204-1212. [PMID: 23453135 DOI: 10.1016/j.jaci.2013.01.014] [Cited by in Crossref: 362] [Cited by in F6Publishing: 324] [Article Influence: 45.3] [Reference Citation Analysis]
370 Huang Y, Elliott MJ, Yolcu ES, Miller TO, Ratajczak J, Bozulic LD, Wen Y, Xu H, Ratajczak MZ, Ildstad ST. Characterization of Human CD8(+)TCR(-) Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγ(null) Mouse Model. Am J Transplant 2016;16:440-53. [PMID: 26550777 DOI: 10.1111/ajt.13511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
371 Fraussen J, Claes N, Van Wijmeersch B, van Horssen J, Stinissen P, Hupperts R, Somers V. B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses. Clin Immunol 2016;173:124-32. [PMID: 27717695 DOI: 10.1016/j.clim.2016.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
372 Martin VG, Wu YB, Townsend CL, Lu GH, O'Hare JS, Mozeika A, Coolen AC, Kipling D, Fraternali F, Dunn-Walters DK. Transitional B Cells in Early Human B Cell Development - Time to Revisit the Paradigm? Front Immunol 2016;7:546. [PMID: 27994589 DOI: 10.3389/fimmu.2016.00546] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
373 Maerz JK, Trostel C, Lange A, Parusel R, Michaelis L, Schäfer A, Yao H, Löw HC, Frick JS. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses. Front Immunol 2019;10:3093. [PMID: 32038631 DOI: 10.3389/fimmu.2019.03093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
374 Hart PA, Zen Y, Chari ST. Recent Advances in Autoimmune Pancreatitis. Gastroenterology 2015;149:39-51. [DOI: 10.1053/j.gastro.2015.03.010] [Cited by in Crossref: 139] [Cited by in F6Publishing: 86] [Article Influence: 23.2] [Reference Citation Analysis]
375 Holan V, Zajicova A, Javorkova E, Trosan P, Chudickova M, Pavlikova M, Krulova M. Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells. Immunology 2014;141:577-86. [PMID: 24256319 DOI: 10.1111/imm.12219] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
376 Khalil MI, Gurski CJ, Dittel LJ, Neu SD, Dittel BN. Discovery and Function of B-Cell IgD Low (BDL) B Cells in Immune Tolerance. J Mol Biol 2021;433:166584. [PMID: 32615130 DOI: 10.1016/j.jmb.2020.06.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Gray D, Gray M. What are regulatory B cells? Eur J Immunol 2010;40:2677-9. [PMID: 21038464 DOI: 10.1002/eji.201040961] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
378 Brocca-Cofano E, Kuhrt D, Siewe B, Xu C, Haret-Richter GS, Craigo J, Labranche C, Montefiori DC, Landay A, Apetrei C, Pandrea I. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction. J Virol 2017;91:e01051-17. [PMID: 28931679 DOI: 10.1128/JVI.01051-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
379 Blumenfeld S, Staun-Ram E, Miller A. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis. J Autoimmun 2016;70:40-51. [PMID: 27055778 DOI: 10.1016/j.jaut.2016.03.012] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 10.4] [Reference Citation Analysis]
380 Liu Y, Wang H, Hu X, Qu Z, Zhang H, Crew R, Ayana DA, Li M, Qiu J, Jiang Y. A higher frequency of IL-10-producing B cells in Hepatitis B virus-associated membranous nephropathy. Clin Exp Pharmacol Physiol 2016;43:417-27. [PMID: 26825579 DOI: 10.1111/1440-1681.12552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
381 Abetov D, Mustapova Z, Saliev T, Bulanin D. Biomarkers and signaling pathways of colorectal cancer stem cells. Tumour Biol. 2015;36:1339-1353. [PMID: 25680406 DOI: 10.1007/s13277-015-3198-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
382 Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ. Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice. Neurology 2019;92:e1724-38. [PMID: 30918100 DOI: 10.1212/WNL.0000000000007262] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 20.5] [Reference Citation Analysis]
383 Mavropoulos A, Liaskos C, Simopoulou T, Bogdanos DP, Sakkas LI. IL-10-producing regulatory B cells (B10 cells), IL-17 + T cells and autoantibodies in systemic sclerosis. Clinical Immunology 2017;184:26-32. [DOI: 10.1016/j.clim.2017.04.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
384 García-Rodríguez S, Rosal-Vela A, Botta D, Cumba Garcia LM, Zumaquero E, Prados-Maniviesa V, Cerezo-Wallis D, Lo Buono N, Robles-Guirado JÁ, Guerrero S, González-Paredes E, Andrés-León E, Corbí Á, Mack M, Koch-Nolte F, Merino R, Zubiaur M, Lund FE, Sancho J. CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism. Sci Rep 2018;8:3357. [PMID: 29463868 DOI: 10.1038/s41598-018-21337-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
385 Ahmetspahic D, Schwarte K, Ambrée O, Bürger C, Falcone V, Seiler K, Kooybaran MR, Grosse L, Roos F, Scheffer J, Jörgens S, Koelkebeck K, Dannlowski U, Arolt V, Scheu S, Alferink J. Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders. J Neuroimmune Pharmacol 2018;13:90-9. [PMID: 28905187 DOI: 10.1007/s11481-017-9763-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
386 Wang X, Wang G, Wang Z, Liu B, Han N, Li J, Lu C, Liu X, Zhang Q, Yang Q, Wang G. PD-1-expressing B cells suppress CD4+ and CD8+ T cells via PD-1/PD-L1-dependent pathway. Molecular Immunology 2019;109:20-6. [DOI: 10.1016/j.molimm.2019.02.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
387 Asai Y, Chiba H, Nishikiori H, Kamekura R, Yabe H, Kondo S, Miyajima S, Shigehara K, Ichimiya S, Takahashi H. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis. Respir Res 2019;20:244. [PMID: 31694639 DOI: 10.1186/s12931-019-1216-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
388 Leyva-Hernández J, Rodríguez-Ortiz U, Arce-Sillas A, Álvarez-Luquín DD, Pérez-Correa CA, Vivas-Almazán AV, Gómez-Hollsten SM, Montes-Moratilla EU, Torres-Velasco ME, Rodríguez-Violante M, Adalid-Peralta LV. Pro- and anti-inflammatory response in neurological disorders associated to anti-glutamate decarboxylase antibodies. J Neuroimmunol 2021;355:577550. [PMID: 33799062 DOI: 10.1016/j.jneuroim.2021.577550] [Reference Citation Analysis]
389 Pers YM, Quentin J, Feirreira R, Espinoza F, Abdellaoui N, Erkilic N, Cren M, Dufourcq-Lopez E, Pullig O, Nöth U, Jorgensen C, Louis-Plence P. Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells. Theranostics 2018;8:5519-28. [PMID: 30555561 DOI: 10.7150/thno.27674] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
390 Latorre I, Esteve-sole A, Redondo D, Giest S, Argilaguet J, Alvarez S, Peligero C, Forstmann I, Crespo M, Pascual J, Meyerhans A. Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients. Transplant Immunology 2016;35:1-6. [DOI: 10.1016/j.trim.2016.01.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
391 Carter CR, Aravind G, Smalle NL, Cole JY, Cherukuri A, Savic S, Wood PM. Do defective B cells contribute to reduced Treg cells and autoimmunity in patients with Common Variable Immunodeficiency? Immunology Letters 2012;148:39-40. [DOI: 10.1016/j.imlet.2012.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
392 Ezekian B, Schroder PM, Freischlag K, Yoon J, Kwun J, Knechtle SJ. Contemporary Strategies and Barriers to Transplantation Tolerance. Transplantation 2018;102:1213-22. [PMID: 29757903 DOI: 10.1097/TP.0000000000002242] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
393 Coca A, Sanz I. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2012;24:451-6. [PMID: 22871954 DOI: 10.1097/BOR.0b013e32835707e4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
394 Chesneau M, Michel L, Dugast E, Chenouard A, Baron D, Pallier A, Durand J, Braza F, Guerif P, Laplaud DA. Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties. J Am Soc Nephrol. 2015;26:2588-2598. [PMID: 25644114 DOI: 10.1681/asn.2014040404] [Cited by in Crossref: 90] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
395 Lai CL, Campbell DE, Palmer DJ, Makrides M, Santner-Nanan B, Gold M, Tan JW, Valerio C, Nanan R, Prescott SL, Hsu PS. Longitudinal egg-specific regulatory T- and B-cell development: Insights from primary prevention clinical trials examining the timing of egg introduction. Allergy 2021;76:1385-97. [PMID: 33040362 DOI: 10.1111/all.14621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Sanz I, Wei C, Jenks SA, Cashman KS, Tipton C, Woodruff MC, Hom J, Lee FE. Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations. Front Immunol 2019;10:2458. [PMID: 31681331 DOI: 10.3389/fimmu.2019.02458] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 33.0] [Reference Citation Analysis]
397 Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010;6:636-43. [DOI: 10.1038/nrrheum.2010.140] [Cited by in Crossref: 128] [Cited by in F6Publishing: 116] [Article Influence: 11.6] [Reference Citation Analysis]
398 Rodgers DT, McGrath MA, Pineda MA, Al-Riyami L, Rzepecka J, Lumb F, Harnett W, Harnett MM. The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice. Arthritis Rheumatol 2015;67:1023-35. [PMID: 25546822 DOI: 10.1002/art.39004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
399 Kabuto M, Fujimoto N, Takahashi T, Tanaka T. Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid. Br J Dermatol 2017;176:1204-12. [PMID: 27716906 DOI: 10.1111/bjd.15113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
400 Sarwal MM. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization. Clin Biochem. 2016;49:404-410. [PMID: 26794635 DOI: 10.1016/j.clinbiochem.2016.01.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
401 Bhattacharyya S. A Review on Biology and Function of Regulatory B Cells with Special Reference to Inflammation and Autoimmune Pathogenesis. Proc Zool Soc 2014;67:1-7. [DOI: 10.1007/s12595-013-0077-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
402 Ma S, Satitsuksanoa P, Jansen K, Cevhertas L, van de Veen W, Akdis M. B regulatory cells in allergy. Immunol Rev 2021;299:10-30. [PMID: 33345311 DOI: 10.1111/imr.12937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
403 Valizadeh A, Sanaei R, Rezaei N, Azizi G, Fekrvand S, Aghamohammadi A, Yazdani R. Potential role of regulatory B cells in immunological diseases. Immunol Lett 2019;215:48-59. [PMID: 31442542 DOI: 10.1016/j.imlet.2019.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
404 Matsushita T, Takehara K. An update on biomarker discovery and use in systemic sclerosis. Expert Review of Molecular Diagnostics 2017;17:823-33. [DOI: 10.1080/14737159.2017.1356722] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
405 Theurich S, Schlaak M, Steguweit H, Heukamp LC, Wennhold K, Kurschat P, Rabenhorst A, Hartmann K, Schlösser H, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Stadler R, von Bergwelt-Baildon M. Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma. J Clin Oncol 2016;34:e110-6. [PMID: 25348001 DOI: 10.1200/JCO.2013.50.9471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
406 Ouyang FZ, Wu RQ, Wei Y, Liu RX, Yang D, Xiao X, Zheng L, Li B, Lao XM, Kuang DM. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma. Nat Commun 2016;7:13453. [PMID: 27853178 DOI: 10.1038/ncomms13453] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
407 Brimnes MK, Hansen BE, Nielsen LK, Dziegiel MH, Nielsen CH. Uptake and presentation of myelin basic protein by normal human B cells. PLoS One 2014;9:e113388. [PMID: 25401487 DOI: 10.1371/journal.pone.0113388] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
408 Sun J, Basu U. Purification of Murine IL-10 + B Cells for Analyses of Biological Functions and Transcriptomics. Methods Mol Biol 2021;2270:307-21. [PMID: 33479906 DOI: 10.1007/978-1-0716-1237-8_17] [Reference Citation Analysis]
409 Alvarez-Rodriguez L, Riancho-Zarrabeitia L, Calvo-Alén J, López-Hoyos M, Martínez-Taboada V. Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome. Int J Mol Sci 2018;19:E589. [PMID: 29462939 DOI: 10.3390/ijms19020589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
410 Ikemiyagi M, Hirai T, Ishii R, Miyairi S, Okumi M, Tanabe K. Transitional B Cells Predominantly Reconstituted After a Desensitization Therapy Using Rituximab Before Kidney Transplantation: B Cell Character After Rituximab. Ther Apher Dial 2017;21:139-49. [DOI: 10.1111/1744-9987.12508] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
411 Gao N, Dresel J, Eckstein V, Gellert R, Störch H, Venigalla RK, Schwenger V, Max R, Blank N, Lorenz HM, Tretter T. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Arthritis Rheumatol 2014;66:2849-61. [PMID: 24942956 DOI: 10.1002/art.38742] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
412 Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmunity Reviews 2017;16:620-32. [DOI: 10.1016/j.autrev.2017.04.012] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 26.8] [Reference Citation Analysis]
413 Traub J, Häusser-Kinzel S, Weber MS. Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients. Int J Mol Sci 2020;21:E5021. [PMID: 32708663 DOI: 10.3390/ijms21145021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
414 Liu Y, Chen Y, Li Z, Han Y, Sun Y, Wang Q, Liu B, Su Z. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Eur J Immunol 2013;43:2907-18. [PMID: 23893352 DOI: 10.1002/eji.201343512] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
415 Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E, Toubi E. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev 2012;11:670-7. [PMID: 22155204 DOI: 10.1016/j.autrev.2011.11.018] [Cited by in Crossref: 185] [Cited by in F6Publishing: 171] [Article Influence: 18.5] [Reference Citation Analysis]
416 Cherukuri A, Salama AD, Carter CR, Landsittel D, Arumugakani G, Clark B, Rothstein DM, Baker RJ. Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function. Kidney Int 2017;91:183-95. [PMID: 28029430 DOI: 10.1016/j.kint.2016.08.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
417 Sambleben C, Knudsen AD, Hartling HJ, Nielsen CH, Nielsen SD. Increased proportions of B cells with spontaneous production of interleukin-10 in HIV-infected individuals are normalized during combination antiretroviral therapy: a longitudinal study. APMIS 2018;126:143-51. [PMID: 29271094 DOI: 10.1111/apm.12795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
418 Bahri R, Bollinger A, Bollinger T, Orinska Z, Bulfone-Paus S. Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-γ-mediated suppressor activities. PLoS One 2012;7:e45234. [PMID: 23028866 DOI: 10.1371/journal.pone.0045234] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
419 van de Veen W, Stanic B, Wirz OF, Jansen K, Globinska A, Akdis M. Role of regulatory B cells in immune tolerance to allergens and beyond. Journal of Allergy and Clinical Immunology 2016;138:654-65. [DOI: 10.1016/j.jaci.2016.07.006] [Cited by in Crossref: 133] [Cited by in F6Publishing: 118] [Article Influence: 26.6] [Reference Citation Analysis]
420 Wang B, Zhu J, Fan Y, Xu W, Cen H, Pan H, Ye D. Association of the −1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis. Gene 2013;519:209-16. [DOI: 10.1016/j.gene.2013.01.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
421 Braza F, Chesne J, Castagnet S, Magnan A, Brouard S. Regulatory functions of B cells in allergic diseases. Allergy 2014;69:1454-63. [DOI: 10.1111/all.12490] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
422 Liu X, Jiang X, Liu R, Wang L, Qian T, Zheng Y, Deng Y, Huang E, Xu F, Wang JY, Chu Y. B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice. Hepatology 2015;62:1563-75. [PMID: 26207521 DOI: 10.1002/hep.28001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
423 Roya N, Fatemeh T, Faramarz MA, Milad SG, Mohammad-Javad S, Najmeh SV, Yousef M, Nader B. Frequency of IL-10+CD19+ B cells in patients with prostate cancer compared to patients with benign prostatic hyperplasia. Afr Health Sci 2020;20:1264-72. [PMID: 33402974 DOI: 10.4314/ahs.v20i3.31] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
424 Soares RR, Antinarelli LMR, Abramo C, Macedo GC, Coimbra ES, Scopel KKG. What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis? Pathog Glob Health 2017;111:107-15. [PMID: 28353409 DOI: 10.1080/20477724.2017.1308902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
425 Zou J, Thornton C, Chambers ES, Rosser EC, Ciurtin C. Exploring the Evidence for an Immunomodulatory Role of Vitamin D in Juvenile and Adult Rheumatic Disease. Front Immunol 2020;11:616483. [PMID: 33679704 DOI: 10.3389/fimmu.2020.616483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Sim JH, Han SS, Lee D, Kim YS, Lee H, Kim H. Analysis of Immune Cell Repopulation After Anti-thymocyte Globulin Administration for Steroid-Resistant T-cell–mediated Rejection. Transplantation Proceedings 2020;52:759-66. [DOI: 10.1016/j.transproceed.2020.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Giacomini E, Rizzo F, Etna MP, Cruciani M, Mechelli R, Buscarinu MC, Pica F, D’agostini C, Salvetti M, Coccia EM, Severa M. Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients. Mult Scler 2018;24:127-39. [DOI: 10.1177/1352458517695892] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
428 Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari CG, Bogdanos DP, Sakkas LI. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis: BREG CELLS IN SYSTEMIC SCLEROSIS. Arthritis & Rheumatology 2016;68:494-504. [DOI: 10.1002/art.39437] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
429 Sakkas LI, Daoussis D, Mavropoulos A, Liossis SN, Bogdanos DP. Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases. Semin Arthritis Rheum. 2019;48:1133-1141. [PMID: 30409417 DOI: 10.1016/j.semarthrit.2018.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
430 Liu F, Dai W, Li C, Lu X, Chen Y, Weng D, Chen J. Role of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis. Sci Rep 2016;6:28911. [PMID: 27354007 DOI: 10.1038/srep28911] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
431 Lynall ME, Kigar SL, Lehmann ML, DePuyt AE, Tuong ZK, Listwak SJ, Elkahloun AG, Bullmore ET, Herkenham M, Clatworthy MR. B-cells are abnormal in psychosocial stress and regulate meningeal myeloid cell activation. Brain Behav Immun 2021:S0889-1591(21)00292-0. [PMID: 34371135 DOI: 10.1016/j.bbi.2021.08.002] [Reference Citation Analysis]
432 Jin J, Gong J, Lin B, Li Y, He Q. FcγRIIb expression on B cells is associated with treatment efficacy for acute rejection after kidney transplantation. Mol Immunol 2017;85:283-92. [PMID: 28360016 DOI: 10.1016/j.molimm.2017.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
433 Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V. CD19 as a molecular target in CNS autoimmunity. Acta Neuropathol 2014;128:177-90. [PMID: 24993505 DOI: 10.1007/s00401-014-1313-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
434 García-hernández M, Rodríguez-varela E, García-jacobo R, Hernández-de la Torre M, Uresti-rivera E, González-amaro R, Portales-pérez D. Frequency of regulatory B cells in adipose tissue and peripheral blood from individuals with overweight, obesity and normal-weight. Obesity Research & Clinical Practice 2018;12:513-9. [DOI: 10.1016/j.orcp.2018.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
435 Alhabbab R, Blair P, Smyth LA, Ratnasothy K, Peng Q, Moreau A, Lechler R, Elgueta R, Lombardi G. Galectin-1 is required for the regulatory function of B cells. Sci Rep 2018;8:2725. [PMID: 29426942 DOI: 10.1038/s41598-018-19965-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
436 Lin W, Jin L, Chen H, Wu Q, Fei Y, Zheng W, Wang Q, Li P, Li Y, Zhang W, Zhao Y, Zeng X, Zhang F. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences. Arthritis Res Ther 2014;16:R118. [PMID: 24887143 DOI: 10.1186/ar4571] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
437 Masat E, Laforêt P, De Antonio M, Corre G, Perniconi B, Taouagh N, Mariampillai K, Amelin D, Mauhin W, Hogrel JY, Caillaud C, Ronzitti G, Puzzo F, Kuranda K, Colella P, Mallone R, Benveniste O, Mingozzi F; French Pompe Registry Study Group. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients. Sci Rep 2016;6:36182. [PMID: 27812025 DOI: 10.1038/srep36182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
438 Schep SJ, Schutgens REG, Fischer K, Voorberg J, Boes M. Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A. Hemasphere 2021;5:e557. [PMID: 33898928 DOI: 10.1097/HS9.0000000000000557] [Reference Citation Analysis]
439 Saraswathula A, Reap EA, Choi BD, Schmittling RJ, Norberg PK, Sayour EJ, Herndon JE 2nd, Healy P, Congdon KL, Archer GE, Sanchez-Perez L, Sampson JH. Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunol Immunother 2016;65:205-11. [PMID: 26759007 DOI: 10.1007/s00262-015-1784-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
440 Field J, Shahijanian F, Schibeci S, Johnson L, Gresle M, Laverick L, Parnell G, Stewart G, McKay F, Kilpatrick T, Butzkueven H, Booth D; Australia and New Zealand MS Genetics Consortium (ANZgene). The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function. PLoS One 2015;10:e0127080. [PMID: 26068105 DOI: 10.1371/journal.pone.0127080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
441 Vadasz Z, Toubi E. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus. Lupus 2012;21:1266-70. [PMID: 22875653 DOI: 10.1177/0961203312456753] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
442 Faith A, Singh N, Farooque S, Dimeloe S, Richards DF, Lu H, Roberts D, Chevretton E, Lee TH, Corrigan CJ, Hawrylowicz CM. T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways. Allergy 2012;67:1007-13. [PMID: 22671764 DOI: 10.1111/j.1398-9995.2012.02852.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
443 Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010;40:2686-91. [PMID: 20809522 DOI: 10.1002/eji.201040673] [Cited by in Crossref: 175] [Cited by in F6Publishing: 166] [Article Influence: 15.9] [Reference Citation Analysis]
444 Lima J, Martins C, Leandro MJ, Nunes G, Sousa MJ, Branco JC, Borrego LM. Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study. BMC Pregnancy Childbirth 2016;16:139. [PMID: 27267973 DOI: 10.1186/s12884-016-0927-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
445 Li R, Bar-Or A. The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies. Cold Spring Harb Perspect Med 2019;9:a029108. [PMID: 29661809 DOI: 10.1101/cshperspect.a029108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
446 Laguna-goya R, Utrero-rico A, Cano-romero FL, Gómez-massa E, González E, Andrés A, Mancebo-sierra E, Paz-artal E. Imbalance favoring follicular helper T cells over IL10+ regulatory B cells is detrimental for the kidney allograft. Kidney International 2020;98:732-43. [DOI: 10.1016/j.kint.2020.02.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
447 Schlößer HA, Thelen M, Lechner A, Wennhold K, Garcia-Marquez MA, Rothschild SI, Staib E, Zander T, Beutner D, Gathof B, Gilles R, Cukuroglu E, Göke J, Shimabukuro-Vornhagen A, Drebber U, Quaas A, Bruns CJ, Hölscher AH, Von Bergwelt-Baildon MS. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies. Oncoimmunology 2019;8:e1512458. [PMID: 30546950 DOI: 10.1080/2162402X.2018.1512458] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
448 Ireland SJ, Guzman AA, O'Brien DE, Hughes S, Greenberg B, Flores A, Graves D, Remington G, Frohman EM, Davis LS, Monson NL. The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis. JAMA Neurol 2014;71:1421-8. [PMID: 25264704 DOI: 10.1001/jamaneurol.2014.1472] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 9.3] [Reference Citation Analysis]
449 Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV. The outliers become a stampede as immunometabolism reaches a tipping point. Immunol Rev 2012;249:253-75. [PMID: 22889227 DOI: 10.1111/j.1600-065X.2012.01142.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
450 Kobashigawa JA. The future of heart transplantation. Am J Transplant 2012;12:2875-91. [PMID: 22900830 DOI: 10.1111/j.1600-6143.2012.04223.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
451 Zhang J, Lapato A, Bodhankar S, Vandenbark AA, Offner H. Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice. Metab Brain Dis 2015;30:1117-27. [PMID: 25776868 DOI: 10.1007/s11011-015-9661-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
452 Guerrier T, Labalette M, Launay D, Lee-Chang C, Outteryck O, Lefèvre G, Vermersch P, Dubucquoi S, Zéphir H. Proinflammatory B-cell profile in the early phases of MS predicts an active disease. Neurol Neuroimmunol Neuroinflamm 2018;5:e431. [PMID: 29296635 DOI: 10.1212/NXI.0000000000000431] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
453 Hilgenberg E, Shen P, Dang VD, Ries S, Sakwa I, Fillatreau S. Interleukin-10-producing B cells and the regulation of immunity. Curr Top Microbiol Immunol 2014;380:69-92. [PMID: 25004814 DOI: 10.1007/978-3-662-43492-5_4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
454 Xue H, Lin F, Tan H, Zhu ZQ, Zhang ZY, Zhao L. Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma. PLoS One 2016;11:e0154815. [PMID: 27136203 DOI: 10.1371/journal.pone.0154815] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
455 Horii M, Matsushita T. Regulatory B cells and T cell Regulation in Cancer. J Mol Biol 2021;433:166685. [PMID: 33096106 DOI: 10.1016/j.jmb.2020.10.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
456 Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun. 2011;12:239-250. [PMID: 21390053 DOI: 10.1038/gene.2011.14] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
457 Mielle J, Audo R, Hahne M, Macia L, Combe B, Morel J, Daien C. IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid Arthritis. Front Immunol 2018;9:961. [PMID: 29774031 DOI: 10.3389/fimmu.2018.00961] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
458 Al-Adhoubi NK, Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus 2020;29:355-63. [PMID: 32036761 DOI: 10.1177/0961203320903798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
459 Cherukuri A, Salama AD, Carter C, Smalle N, McCurtin R, Hewitt EW, Hernandez-Fuentes M, Clark B, Baker RJ. An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. Am J Transplant. 2012;12:919-931. [PMID: 22390816 DOI: 10.1111/j.1600-6143.2011.03891.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
460 Li W, Tian X, Lu X, Peng Q, Shu X, Yang H, Li Y, Wang Y, Zhang X, Liu Q, Wang G. Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis. Sci Rep 2016;6:27479. [PMID: 27270362 DOI: 10.1038/srep27479] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
461 Lykken JM, Candando KM, Tedder TF. Regulatory B10 cell development and function. Int Immunol 2015;27:471-7. [PMID: 26254185 DOI: 10.1093/intimm/dxv046] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 14.0] [Reference Citation Analysis]
462 Baecher-allan C, Kaskow BJ, Weiner HL. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron 2018;97:742-68. [DOI: 10.1016/j.neuron.2018.01.021] [Cited by in Crossref: 274] [Cited by in F6Publishing: 225] [Article Influence: 91.3] [Reference Citation Analysis]
463 Edozie FC, Nova-Lamperti EA, Povoleri GA, Scottà C, John S, Lombardi G, Afzali B. Regulatory T-cell therapy in the induction of transplant tolerance: the issue of subpopulations. Transplantation. 2014;98:370-379. [PMID: 24933458 DOI: 10.1097/tp.0000000000000243] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
464 Sakkas LI, Bogdanos DP. Systemic sclerosis: New evidence re-enforces the role of B cells. Autoimmun Rev 2016;15:155-61. [PMID: 26497107 DOI: 10.1016/j.autrev.2015.10.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
465 Cherukuri A, Salama AD, Mehta R, Mohib K, Zheng L, Magee C, Harber M, Stauss H, Baker RJ, Tevar A, Landsittel D, Lakkis FG, Hariharan S, Rothstein DM. Transitional B cell cytokines predict renal allograft outcomes. Sci Transl Med 2021;13:eabe4929. [PMID: 33627487 DOI: 10.1126/scitranslmed.abe4929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
466 Schlößer HA, Thelen M, Dieplinger G, von Bergwelt-baildon A, Garcia-marquez M, Reuter S, Shimabukuro-vornhagen A, Wennhold K, Haustein N, Buchner D, Heiermann N, Kleinert R, Wahba R, Ditt V, Kurschat C, Cingöz T, Becker J, Stippel DL, von Bergwelt-baildon M. Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients. Am J Transplant 2017;17:542-50. [DOI: 10.1111/ajt.14013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
467 Tull TJ, Pitcher MJ, Guesdon W, Siu JHY, Lebrero-Fernández C, Zhao Y, Petrov N, Heck S, Ellis R, Dhami P, Kadolsky UD, Kleeman M, Kamra Y, Fear DJ, John S, Jassem W, Groves RW, Sanderson JD, Robson MD, D'Cruz DP, Bemark M, Spencer J. Human marginal zone B cell development from early T2 progenitors. J Exp Med 2021;218:e20202001. [PMID: 33538776 DOI: 10.1084/jem.20202001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
468 Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol 2017;8:1773. [PMID: 29379494 DOI: 10.3389/fimmu.2017.01773] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
469 Kader HA, Azeem M, Jwayed SA, Al-Shehhi A, Tabassum A, Ayoub MA, Hetta HF, Waheed Y, Iratni R, Al-Dhaheri A, Muhammad K. Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis. Cells 2021;10:1392. [PMID: 34200009 DOI: 10.3390/cells10061392] [Reference Citation Analysis]
470 Bautista-Caro MB, de Miguel E, Peiteado D, Plasencia-Rodríguez C, Villalba A, Monjo-Henry I, Puig-Kröger A, Sánchez-Mateos P, Martín-Mola E, Miranda-Carús ME. Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents. PLoS One 2017;12:e0180726. [PMID: 28683133 DOI: 10.1371/journal.pone.0180726] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
471 Qian J, Yu Q, Chen G, Wang M, Zhao Z, Zhang Y, Qiu L. Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection. Clin Exp Med 2020;20:373-80. [PMID: 32206927 DOI: 10.1007/s10238-020-00621-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Kalampokis I, Yoshizaki A, Tedder TF. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther. 2013;15 Suppl 1:S1. [PMID: 23566714 DOI: 10.1186/ar3907] [Cited by in Crossref: 199] [Cited by in F6Publishing: 187] [Article Influence: 24.9] [Reference Citation Analysis]
473 Schwartz M, Zhang Y, Rosenblatt JD. B cell regulation of the anti-tumor response and role in carcinogenesis. J Immunother Cancer. 2016;4:40. [PMID: 27437104 DOI: 10.1186/s40425-016-0145-x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 105] [Article Influence: 22.4] [Reference Citation Analysis]
474 Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, Zippelius A, Mayer F, Reck M, Atanackovic D, Thomas M, Schneller F, Stöhlmacher J, Bernhard H, Gröschel A, Lander T, Probst J, Strack T, Wiegand V, Gnad-Vogt U, Kallen KJ, Hoerr I, von der Muelbe F, Fotin-Mleczek M, Knuth A, Koch SD. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. Cancer Immunol Immunother 2019;68:799-812. [PMID: 30770959 DOI: 10.1007/s00262-019-02315-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
475 Sun G, Wang Y, Ti Y, Wang J, Zhao J, Qian H. Regulatory B cell is critical in bone union process through suppressing proinflammatory cytokines and stimulating Foxp3 in Treg cells. Clin Exp Pharmacol Physiol 2017;44:455-62. [DOI: 10.1111/1440-1681.12719] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
476 Mackern-Oberti JP, Jara EL, Riedel CA, Kalergis AM. Hormonal Modulation of Dendritic Cells Differentiation, Maturation and Function: Implications for the Initiation and Progress of Systemic Autoimmunity. Arch Immunol Ther Exp (Warsz) 2017;65:123-36. [PMID: 27585815 DOI: 10.1007/s00005-016-0418-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
477 Jiao Y, Wang X, Zhang T, Lijun S, Wang R, Li W, Ji Y, Wu H, Liu C. Regulatory B cells correlate with HIV disease progression: Regulatory B cells in HIV progression. Microbiol Immunol 2014;58:449-55. [DOI: 10.1111/1348-0421.12171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
478 Hu Y, He GL, Zhao XY, Zhao XS, Wang Y, Xu LP, Zhang XH, Yu XZ, Liu KY, Chang YJ, Huang XJ. Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation. Oncoimmunology 2017;6:e1284721. [PMID: 28405514 DOI: 10.1080/2162402X.2017.1284721] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
479 Zhu G, Liu Y, Zhang W, Huang Y, Li K. CD27+TIM-1+ memory B cells promoted the development of Foxp3+ Tregs and were associated with better survival in acute respiratory distress syndrome. Immunol Res 2018;66:281-7. [PMID: 29392553 DOI: 10.1007/s12026-017-8983-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
480 Unizony S, Lim N, Phippard DJ, Carey VJ, Miloslavsky EM, Tchao NK, Iklé D, Asare AL, Merkel PA, Monach PA, Seo P, St Clair EW, Langford CA, Spiera R, Hoffman GS, Kallenberg CG, Specks U, Stone JH. Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 2015;67:535-44. [PMID: 25332071 DOI: 10.1002/art.38916] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
481 Lima J, Martins C, Nunes G, Sousa M, Branco JC, Borrego LM. Impact of Labor on Peripheral Blood Maternal T-Cell Subsets and on Regulatory T and B Cells. Reprod Sci 2016;24:276-84. [DOI: 10.1177/1933719116653680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
482 Obermoser G, Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus 2010;19:1012-9. [PMID: 20693194 DOI: 10.1177/0961203310371161] [Cited by in Crossref: 161] [Cited by in F6Publishing: 136] [Article Influence: 14.6] [Reference Citation Analysis]
483 Mohib K, Cherukuri A, Rothstein DM. Regulatory B cells and transplantation: almost prime time? Curr Opin Organ Transplant 2018;23:524-32. [PMID: 30045092 DOI: 10.1097/MOT.0000000000000559] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
484 Guilbride DL, Guilbride PD, Gawlinski P. Malaria's deadly secret: a skin stage. Trends in Parasitology 2012;28:142-50. [DOI: 10.1016/j.pt.2012.01.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
485 Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, Mauri C. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 2013;5:173ra23. [PMID: 23427243 DOI: 10.1126/scitranslmed.3005407] [Cited by in Crossref: 391] [Cited by in F6Publishing: 363] [Article Influence: 48.9] [Reference Citation Analysis]
486 Todd SK, Pepper RJ, Draibe J, Tanna A, Pusey CD, Mauri C, Salama AD. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 2014;53:1693-703. [PMID: 24729396 DOI: 10.1093/rheumatology/keu136] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
487 Busse M, Redlich A, Hartig R, Costa SD, Rathert H, Fest S, Zenclussen AC. Imbalance between inflammatory and regulatory cord blood B cells following pre-term birth. J Reprod Immunol 2021;145:103319. [PMID: 33848896 DOI: 10.1016/j.jri.2021.103319] [Reference Citation Analysis]
488 Hasan MM, Thompson-Snipes L, Klintmalm G, Demetris AJ, O'Leary J, Oh S, Joo H. CD24hiCD38hi and CD24hiCD27+ Human Regulatory B Cells Display Common and Distinct Functional Characteristics. J Immunol 2019;203:2110-20. [PMID: 31511354 DOI: 10.4049/jimmunol.1900488] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
489 Zhao L, Ye Y, Zhang X. B cells biology in systemic lupus erythematosus—from bench to bedside. Sci China Life Sci 2015;58:1111-25. [DOI: 10.1007/s11427-015-4953-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
490 Thaunat O. Pathophysiologic Significance of B-Cell Clusters in Chronically Rejected Grafts. Transplantation 2011;92:121-6. [DOI: 10.1097/tp.0b013e31821f74fe] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
491 Lepse N, Abdulahad WH, Rutgers A, Kallenberg CGM, Stegeman CA, Heeringa P. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology 2014;53:1683-92. [DOI: 10.1093/rheumatology/keu149] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
492 Bankó Z, Pozsgay J, Szili D, Tóth M, Gáti T, Nagy G, Rojkovich B, Sármay G. Induction and Differentiation of IL-10-Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients. J Immunol 2017;198:1512-20. [PMID: 28087671 DOI: 10.4049/jimmunol.1600218] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 14.5] [Reference Citation Analysis]
493 Egbuniwe IU, Karagiannis SN, Nestle FO, Lacy KE. Revisiting the role of B cells in skin immune surveillance. Trends Immunol. 2015;36:102-111. [PMID: 25616715 DOI: 10.1016/j.it.2014.12.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
494 Balkwill F, Montfort A, Capasso M. B regulatory cells in cancer. Trends Immunol. 2013;34:169-173. [PMID: 23206438 DOI: 10.1016/j.it.2012.10.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
495 Bao W, Zhong H, Manwani D, Vasovic L, Uehlinger J, Lee MT, Sheth S, Shi P, Yazdanbakhsh K. Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am J Hematol 2013;88:736-40. [PMID: 23720018 DOI: 10.1002/ajh.23488] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
496 van de Veen W. The role of regulatory B cells in allergen immunotherapy. Curr Opin Allergy Clin Immunol 2017;17:447-52. [PMID: 28957824 DOI: 10.1097/ACI.0000000000000400] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 10.7] [Reference Citation Analysis]
497 Ponnuswamy P, Joffre J, Herbin O, Esposito B, Laurans L, Binder CJ, Tedder TF, Zeboudj L, Loyer X, Giraud A, Zhang Y, Tedgui A, Mallat Z, Ait-Oufella H. Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells. Sci Rep 2017;7:4111. [PMID: 28646220 DOI: 10.1038/s41598-017-04438-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
498 Dörner T, Jacobi AM, Lee J, Lipsky PE. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods 2011;363:187-97. [PMID: 20598709 DOI: 10.1016/j.jim.2010.06.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 7.7] [Reference Citation Analysis]
499 Papakrivopoulou E, Shendi AM, Salama AD, Khosravi M, Connolly JO, Trompeter R. Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease. Nephrology (Carlton) 2016;21:893-900. [PMID: 26860320 DOI: 10.1111/nep.12744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
500 Baba Y, Saito Y, Kotetsu Y. Heterogeneous subsets of B-lineage regulatory cells (Breg cells). Int Immunol 2020;32:155-62. [PMID: 31630184 DOI: 10.1093/intimm/dxz068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
501 Wang R, Xie R, Song Z. Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells. Experimental Cell Research 2018;365:171-6. [DOI: 10.1016/j.yexcr.2018.02.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
502 Ding T, Su R, Wu R, Xue H, Wang Y, Su R, Gao C, Li X, Wang C. Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells. Front Immunol 2021;12:641013. [PMID: 33841422 DOI: 10.3389/fimmu.2021.641013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Chesneau M, Mai HL, Danger R, Le Bot S, Nguyen T, Bernard J, Poullaouec C, Guerrif P, Conchon S, Giral M, Charreau B, Degauque N, Brouard S. Efficient Expansion of Human Granzyme B–Expressing B Cells with Potent Regulatory Properties. J I 2020;205:2391-401. [DOI: 10.4049/jimmunol.2000335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
504 Liu J, Wang H, Yu Q, Zheng S, Jiang Y, Liu Y, Yuan G, Qiu L. RETRACTED: Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in Non Small Cell Lung Carcinoma patients. Hum Immunol 2016;77:84-9. [PMID: 26527508 DOI: 10.1016/j.humimm.2015.10.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
505 Hua F, Ji L, Zhan Y, Li F, Zou S, Wang X, Song D, Min Z, Gao S, Wu Y, Chen H, Cheng Y. Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia. J Clin Immunol 2012;32:1233-42. [PMID: 22669326 DOI: 10.1007/s10875-012-9714-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
506 Furuzawa-Carballeda J, Lima G, Simancas P, Ramos-Bello D, Simancas M, Bostock IC, Vilatobá M, Gabilondo B, Granados J, Morales-Buenrostro L, Alberú J, Llorente L. Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study. J Transplant 2012;2012:256960. [PMID: 23213488 DOI: 10.1155/2012/256960] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
507 Suga H, Sato S. IL ‐10–producing regulatory B cells in skin diseases. J Cutan Immunol Allergy 2019;2:68-74. [DOI: 10.1002/cia2.12059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Hayashi M, Yanaba K, Umezawa Y, Yoshihara Y, Kikuchi S, Ishiuji Y, Saeki H, Nakagawa H. IL-10-producing regulatory B cells are decreased in patients with psoriasis. Journal of Dermatological Science 2016;81:93-100. [DOI: 10.1016/j.jdermsci.2015.11.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
509 van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans AK, Liu KY, Barr TA, Sparwasser T, Boon L, Ngoa UA, Feugap EN, Adegnika AA, Kremsner PG, Gray D, Yazdanbakhsh M, Smits HH. Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One 2012;7:e30883. [PMID: 22347409 DOI: 10.1371/journal.pone.0030883] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
510 Amrouche K, Pers J, Jamin C. Glatiramer Acetate Stimulates Regulatory B Cell Functions. J I 2019;202:1970-80. [DOI: 10.4049/jimmunol.1801235] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
511 Vadasz Z, Haj T, Balbir A, Peri R, Rosner I, Slobodin G, Kessel A, Toubi E. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Semin Arthritis Rheum 2014;43:767-71. [PMID: 24461079 DOI: 10.1016/j.semarthrit.2013.11.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
512 Ticha O, Slanina P, Moos L, Stichova J, Vlkova M, Bekeredjian-Ding I. TNFR2 expression is a hallmark of human memory B cells with suppressive function. Eur J Immunol 2021;51:1195-205. [PMID: 33609401 DOI: 10.1002/eji.202048988] [Reference Citation Analysis]
513 Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin NA, Shoenfeld Y, Toubi E. Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Clinical Immunology 2016;164:114-8. [DOI: 10.1016/j.clim.2016.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
514 Keijzers M, Nogales-gadea G, de Baets M. Clinical and scientific aspects of acetylcholine receptor myasthenia gravis. Current Opinion in Neurology 2014;27:552-7. [DOI: 10.1097/wco.0000000000000125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
515 Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 2020;16:19-30. [PMID: 30796732 DOI: 10.1007/s12519-019-00229-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 17.0] [Reference Citation Analysis]
516 Tobón GJ, Izquierdo JH, Cañas CA. B lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus. Autoimmune Dis 2013;2013:827254. [PMID: 24187614 DOI: 10.1155/2013/827254] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
517 Oleinika K, Mauri C, Salama AD. Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol 2019;15:11-26. [DOI: 10.1038/s41581-018-0074-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
518 Gupta S, Agrawal S, Gollapudi S. Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans. Immun Ageing 2013;10:3. [PMID: 23343052 DOI: 10.1186/1742-4933-10-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
519 Staun-Ram E, Miller A. Effector and regulatory B cells in Multiple Sclerosis. Clin Immunol 2017;184:11-25. [PMID: 28461106 DOI: 10.1016/j.clim.2017.04.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
520 Liu J, Liu Q, Chen X. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells. Front Immunol 2020;11:1843. [PMID: 32922398 DOI: 10.3389/fimmu.2020.01843] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
521 Mauri C. Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 2010;22:761-7. [PMID: 21087847 DOI: 10.1016/j.coi.2010.10.009] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 8.0] [Reference Citation Analysis]
522 Peng L, Zhang Y, Wang Z. Immune Responses against Disseminated Tumor Cells. Cancers (Basel) 2021;13:2515. [PMID: 34063848 DOI: 10.3390/cancers13112515] [Reference Citation Analysis]
523 Forsthuber TG, Cimbora DM, Ratchford JN, Katz E, Stüve O. B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets. Ther Adv Neurol Disord 2018;11:1756286418761697. [PMID: 29593838 DOI: 10.1177/1756286418761697] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
524 Lin X, Lu L. B Cell-Mediated Autoimmune Diseases. Adv Exp Med Biol 2020;1254:145-60. [PMID: 32323275 DOI: 10.1007/978-981-15-3532-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
525 Li J, Gao J, Zhou H, Zhou J, Deng Z, Lu Y, Rao J, Ji G, Gu J, Yang X, Xia Y, Wang X. Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19+CD24hiCD27+ Breg Cells. Front Immunol 2020;11:603288. [PMID: 33343576 DOI: 10.3389/fimmu.2020.603288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
526 Abu-Raya B, Michalski C, Sadarangani M, Lavoie PM. Maternal Immunological Adaptation During Normal Pregnancy. Front Immunol 2020;11:575197. [PMID: 33133091 DOI: 10.3389/fimmu.2020.575197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
527 Furuzawa-carballeda J, Bostock IC, Lima G, Mancilla-urrea E, Mondragón G, Reyes-acevedo R, Chevaile A, Morales-buenrostro LE, Llorente L, Alberú J. Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment. Transplant Immunology 2014;30:107-13. [DOI: 10.1016/j.trim.2014.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
528 Chulanetra M, Chaicumpa W. Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites. Front Cell Infect Microbiol 2021;11:702125. [PMID: 34395313 DOI: 10.3389/fcimb.2021.702125] [Reference Citation Analysis]
529 Qiu J, Zhou F, Li X, Zhang S, Chen Z, Xu Z, Lu G, Zhu Z, Ding N, Lou J, Ye Z, Qian Q. Changes and Clinical Significance of Detailed Peripheral Lymphocyte Subsets in Evaluating the Immunity for Cancer Patients. Cancer Manag Res 2020;12:209-19. [PMID: 32021437 DOI: 10.2147/CMAR.S221586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Tan Y, Zhao M, Xiang B, Chang C, Lu Q. CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases. Clinic Rev Allerg Immunol 2016;50:70-83. [DOI: 10.1007/s12016-015-8470-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
531 Kofod-olsen E, Jørgensen SE, Nissen SK, Westh L, Møller BK, Østergaard L, Larsen CS, Mogensen TH. Altered fraction of regulatory B and T cells is correlated with autoimmune phenomena and splenomegaly in patients with CVID. Clinical Immunology 2016;162:49-57. [DOI: 10.1016/j.clim.2015.11.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
532 Todeschini M, Cortinovis M, Perico N, Poli F, Innocente A, Cavinato RA, Gotti E, Ruggenenti P, Gaspari F, Noris M, Remuzzi G, Casiraghi F. In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development. J I 2013;191:2818-28. [DOI: 10.4049/jimmunol.1203261] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
533 Ben Nasr M, Usuelli V, Seelam AJ, D'Addio F, Abdi R, Markmann JF, Fiorina P. Regulatory B Cells in Autoimmune Diabetes. J Immunol 2021;206:1117-25. [PMID: 33685919 DOI: 10.4049/jimmunol.2001127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Miyazaki Y, Niino M, Fukazawa T, Takahashi E, Nonaka T, Amino I, Tashiro J, Minami N, Fujiki N, Doi S, Kikuchi S. Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations. Clinical Immunology 2014;151:127-35. [DOI: 10.1016/j.clim.2014.02.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
535 Yu J, Duong VHH, Westphal K, Westphal A, Suwandi A, Grassl GA, Brand K, Chan AC, Föger N, Lee KH. Surface receptor Toso controls B cell-mediated regulation of T cell immunity. J Clin Invest 2018;128:1820-36. [PMID: 29461978 DOI: 10.1172/JCI97280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
536 Bibby JA, Purvis HA, Hayday T, Chandra A, Okkenhaug K, Rosenzweig S, Aksentijevich I, Wood M, Lachmann HJ, Kemper C, Cope AP, Perucha E. Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate. Nat Commun 2020;11:3412. [PMID: 32641742 DOI: 10.1038/s41467-020-17179-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
537 Saraux A, Pers JO, Devauchelle-Pensec V. Treatment of primary Sjögren syndrome. Nat Rev Rheumatol 2016;12:456-71. [PMID: 27411907 DOI: 10.1038/nrrheum.2016.100] [Cited by in Crossref: 90] [Cited by in F6Publishing: 64] [Article Influence: 18.0] [Reference Citation Analysis]
538 Zwang NA, Ganesh BB, Cardenas KT, Chong AS, Finn PW, Perkins DL. An optimized protocol to quantify signaling in human transitional B cells by phospho flow cytometry. J Immunol Methods 2018;463:112-21. [PMID: 30321549 DOI: 10.1016/j.jim.2018.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
539 Nouatin O, Ateba Ngoa U, Ibáñez J, Dejon-Agobe JC, Mordmüller B, Edoa JR, Mougeni F, Brückner S, Bouyoukou Hounkpatin A, Esen M, Theisen M, Moutairou K, Hoffman SL, Issifou S, Luty AJF, Loembe MM, Agnandji ST, Lell B, Kremsner PG, Adegnika AA. Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults. Vaccine 2020;38:4263-72. [PMID: 32386747 DOI: 10.1016/j.vaccine.2020.04.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
540 Mahata B, Zhang X, Kolodziejczyk AA, Proserpio V, Haim-Vilmovsky L, Taylor AE, Hebenstreit D, Dingler FA, Moignard V, Göttgens B, Arlt W, McKenzie AN, Teichmann SA. Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis. Cell Rep 2014;7:1130-42. [PMID: 24813893 DOI: 10.1016/j.celrep.2014.04.011] [Cited by in Crossref: 139] [Cited by in F6Publishing: 121] [Article Influence: 19.9] [Reference Citation Analysis]
541 Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P. Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use. J Am Soc Nephrol 2019;30:1206-19. [PMID: 31227636 DOI: 10.1681/ASN.2018121254] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
542 Wang WM, Guo L, Jin HZ. Role of B cells in immune-mediated dermatoses. Mol Immunol 2020;126:95-100. [PMID: 32795664 DOI: 10.1016/j.molimm.2020.07.016] [Reference Citation Analysis]
543 Shiu KY, Stringer D, McLaughlin L, Shaw O, Brookes P, Burton H, Wilkinson H, Douthwaite H, Tsui TL, Mclean A, Hilton R, Griffin S, Geddes C, Ball S, Baker R, Roufosse C, Horsfield C, Dorling A. Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts. Front Immunol 2020;11:79. [PMID: 32117242 DOI: 10.3389/fimmu.2020.00079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
544 Imbrechts M, Avau A, Vandenhaute J, Malengier-Devlies B, Put K, Mitera T, Berghmans N, Burton O, Junius S, Liston A, de Somer L, Wouters C, Matthys P. Insufficient IL-10 Production as a Mechanism Underlying the Pathogenesis of Systemic Juvenile Idiopathic Arthritis. J Immunol 2018;201:2654-63. [PMID: 30266771 DOI: 10.4049/jimmunol.1800468] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
545 Chand Dakal T, Dhabhai B, Agarwal D, Gupta R, Nagda G, Meena AR, Dhakar R, Menon A, Mathur R, Mona, Yadav V, Sharma A. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders. Immunobiology 2020;225:151899. [PMID: 31899051 DOI: 10.1016/j.imbio.2019.151899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
546 Jin L, Weiqian C, Lihuan Y. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus. Int J Rheum Dis 2013;16:698-708. [PMID: 24286662 DOI: 10.1111/1756-185X.12229] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
547 Meyer-Bahlburg A, Rawlings DJ. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front Biosci (Landmark Ed) 2012;17:1499-516. [PMID: 22201817 DOI: 10.2741/4000] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
548 Zheng Z, Liu T, Li X, Ding J, Feng Y, Miao J, Luo X, Wu Z, Zhu P. Kinetic changes of regulatory B10 cells in collagen-induced arthritis could be regulated by cytokines IFN-γ and TGF-β1. Inflamm Res 2015;64:637-45. [DOI: 10.1007/s00011-015-0846-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
549 Bankó Z, Pozsgay J, Gáti T, Rojkovich B, Ujfalussy I, Sármay G. Regulatory B cells in rheumatoid arthritis: Alterations in patients receiving anti-TNF therapy. Clinical Immunology 2017;184:63-9. [DOI: 10.1016/j.clim.2017.05.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
550 Kondo K, Shaim H, Thompson PA, Burger JA, Keating M, Estrov Z, Harris D, Kim E, Ferrajoli A, Daher M, Basar R, Muftuoglu M, Imahashi N, Alsuliman A, Sobieski C, Gokdemir E, Wierda W, Jain N, Liu E, Shpall EJ, Rezvani K. Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. Leukemia 2018;32:960-70. [PMID: 28972595 DOI: 10.1038/leu.2017.304] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 17.0] [Reference Citation Analysis]
551 Ryan GA, Wang CJ, Chamberlain JL, Attridge K, Schmidt EM, Kenefeck R, Clough LE, Dunussi-Joannopoulos K, Toellner KM, Walker LS. B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol 2010;185:2800-7. [PMID: 20675587 DOI: 10.4049/jimmunol.1000856] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
552 Ma QY, Chen J, Zhao J. Follicular cytotoxic CD8 T cells present high cytokine expression, and are more susceptible to Breg-mediated suppression in non-small cell lung cancer. Immunol Res 2020;68:54-62. [PMID: 32128664 DOI: 10.1007/s12026-020-09120-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
553 Buffa S, Pellicanò M, Bulati M, Martorana A, Goldeck D, Caruso C, Pawelec G, Colonna-Romano G. A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordr). 2013;35:2009-2024. [PMID: 23129025 DOI: 10.1007/s11357-012-9488-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
554 Anolik J. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care? J Rheumatol 2011;38:587-9. [PMID: 21459953 DOI: 10.3899/jrheum.101350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
555 Li S, Ma F, Hao H, Wang D, Gao Y, Zhou J, Li F, Lin H, Xiao X, Zeng Q. Marked elevation of circulating CD19 + CD38 hi CD24 hi transitional B cells give protection against neonatal sepsis. Pediatrics & Neonatology 2018;59:296-304. [DOI: 10.1016/j.pedneo.2017.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
556 Nova-Lamperti E, Chana P, Mobillo P, Runglall M, Kamra Y, McGregor R, Lord GM, Lechler RI, Lombardi G, Hernandez-Fuentes MP; GAMBIT Study. Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients. Transplantation 2017;101:541-7. [PMID: 27472092 DOI: 10.1097/TP.0000000000001341] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
557 Liu CL, Ye P, Lin J, Butts CL, Miao CH. Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice. Front Immunol 2014;4:502. [PMID: 24432019 DOI: 10.3389/fimmu.2013.00502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
558 Zhang Y, Morgan R, Chen C, Cai Y, Clark E, Khan WN, Shin SU, Cho HM, Al Bayati A, Pimentel A, Rosenblatt JD. Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses. Int Immunol 2016;28:423-33. [PMID: 26895637 DOI: 10.1093/intimm/dxw007] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
559 Garraud O, Borhis G, Badr G, Degrelle S, Pozzetto B, Cognasse F, Richard Y. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol 2012;13:63. [PMID: 23194300 DOI: 10.1186/1471-2172-13-63] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
560 Li J, Sun W, Subrahmanyam PB, Page C, Younger KM, Tiper IV, Frieman M, Kimball AS, Webb TJ. NKT Cell Responses to B Cell Lymphoma. Med Sci (Basel) 2014;2:82-97. [PMID: 24955247 DOI: 10.3390/medsci2020082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
561 Karahan GE, Claas FH, Heidt S. Detecting the humoral alloimmune response: we need more than serum antibody screening. Transplantation 2015;99:908-15. [PMID: 25839708 DOI: 10.1097/TP.0000000000000724] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
562 Basten A, Silveira PA. B-cell tolerance: mechanisms and implications. Curr Opin Immunol 2010;22:566-74. [PMID: 20829011 DOI: 10.1016/j.coi.2010.08.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
563 Cho EB, Cho HJ, Seok JM, Min JH, Kang ES, Kim BJ. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder. Neurol Sci 2018;39:543-9. [PMID: 29349658 DOI: 10.1007/s10072-018-3248-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
564 Geginat J, Larghi P, Paroni M, Nizzoli G, Penatti A, Pagani M, Gagliani N, Meroni P, Abrignani S, Flavell RA. The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. Cytokine & Growth Factor Reviews 2016;30:87-93. [DOI: 10.1016/j.cytogfr.2016.02.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 12.6] [Reference Citation Analysis]
565 Cossarizza A, Chang HD, Radbruch A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, Allez M, Almeida LN, Alvisi G, Anderson G, Andrä I, Annunziato F, Anselmo A, Bacher P, Baldari CT, Bari S, Barnaba V, Barros-Martins J, Battistini L, Bauer W, Baumgart S, Baumgarth N, Baumjohann D, Baying B, Bebawy M, Becher B, Beisker W, Benes V, Beyaert R, Blanco A, Boardman DA, Bogdan C, Borger JG, Borsellino G, Boulais PE, Bradford JA, Brenner D, Brinkman RR, Brooks AES, Busch DH, Büscher M, Bushnell TP, Calzetti F, Cameron G, Cammarata I, Cao X, Cardell SL, Casola S, Cassatella MA, Cavani A, Celada A, Chatenoud L, Chattopadhyay PK, Chow S, Christakou E, Čičin-Šain L, Clerici M, Colombo FS, Cook L, Cooke A, Cooper AM, Corbett AJ, Cosma A, Cosmi L, Coulie PG, Cumano A, Cvetkovic L, Dang VD, Dang-Heine C, Davey MS, Davies D, De Biasi S, Del Zotto G, Dela Cruz GV, Delacher M, Della Bella S, Dellabona P, Deniz G, Dessing M, Di Santo JP, Diefenbach A, Dieli F, Dolf A, Dörner T, Dress RJ, Dudziak D, Dustin M, Dutertre CA, Ebner F, Eckle SBG, Edinger M, Eede P, Ehrhardt GRA, Eich M, Engel P, Engelhardt B, Erdei A, Esser C, Everts B, Evrard M, Falk CS, Fehniger TA, Felipo-Benavent M, Ferry H, Feuerer M, Filby A, Filkor K, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frehse B, Frenette PS, Frischbutter S, Fritzsche W, Galbraith DW, Gangaev A, Garbi N, Gaudilliere B, Gazzinelli RT, Geginat J, Gerner W, Gherardin NA, Ghoreschi K, Gibellini L, Ginhoux F, Goda K, Godfrey DI, Goettlinger C, González-Navajas JM, Goodyear CS, Gori A, Grogan JL, Grummitt D, Grützkau A, Haftmann C, Hahn J, Hammad H, Hämmerling G, Hansmann L, Hansson G, Harpur CM, Hartmann S, Hauser A, Hauser AE, Haviland DL, Hedley D, Hernández DC, Herrera G, Herrmann M, Hess C, Höfer T, Hoffmann P, Hogquist K, Holland T, Höllt T, Holmdahl R, Hombrink P, Houston JP, Hoyer BF, Huang B, Huang FP, Huber JE, Huehn J, Hundemer M, Hunter CA, Hwang WYK, Iannone A, Ingelfinger F, Ivison SM, Jäck HM, Jani PK, Jávega B, Jonjic S, Kaiser T, Kalina T, Kamradt T, Kaufmann SHE, Keller B, Ketelaars SLC, Khalilnezhad A, Khan S, Kisielow J, Klenerman P, Knopf J, Koay HF, Kobow K, Kolls JK, Kong WT, Kopf M, Korn T, Kriegsmann K, Kristyanto H, Kroneis T, Krueger A, Kühne J, Kukat C, Kunkel D, Kunze-Schumacher H, Kurosaki T, Kurts C, Kvistborg P, Kwok I, Landry J, Lantz O, Lanuti P, LaRosa F, Lehuen A, LeibundGut-Landmann S, Leipold MD, Leung LYT, Levings MK, Lino AC, Liotta F, Litwin V, Liu Y, Ljunggren HG, Lohoff M, Lombardi G, Lopez L, López-Botet M, Lovett-Racke AE, Lubberts E, Luche H, Ludewig B, Lugli E, Lunemann S, Maecker HT, Maggi L, Maguire O, Mair F, Mair KH, Mantovani A, Manz RA, Marshall AJ, Martínez-Romero A, Martrus G, Marventano I, Maslinski W, Matarese G, Mattioli AV, Maueröder C, Mazzoni A, McCluskey J, McGrath M, McGuire HM, McInnes IB, Mei HE, Melchers F, Melzer S, Mielenz D, Miller SD, Mills KHG, Minderman H, Mjösberg J, Moore J, Moran B, Moretta L, Mosmann TR, Müller S, Multhoff G, Muñoz LE, Münz C, Nakayama T, Nasi M, Neumann K, Ng LG, Niedobitek A, Nourshargh S, Núñez G, O'Connor JE, Ochel A, Oja A, Ordonez D, Orfao A, Orlowski-Oliver E, Ouyang W, Oxenius A, Palankar R, Panse I, Pattanapanyasat K, Paulsen M, Pavlinic D, Penter L, Peterson P, Peth C, Petriz J, Piancone F, Pickl WF, Piconese S, Pinti M, Pockley AG, Podolska MJ, Poon Z, Pracht K, Prinz I, Pucillo CEM, Quataert SA, Quatrini L, Quinn KM, Radbruch H, Radstake TRDJ, Rahmig S, Rahn HP, Rajwa B, Ravichandran G, Raz Y, Rebhahn JA, Recktenwald D, Reimer D, Reis e Sousa C, Remmerswaal EBM, Richter L, Rico LG, Riddell A, Rieger AM, Robinson JP, Romagnani C, Rubartelli A, Ruland J, Saalmüller A, Saeys Y, Saito T, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sandrock I, Santoni A, Sanz RB, Saresella M, Sautes-Fridman C, Sawitzki B, Schadt L, Scheffold A, Scherer HU, Schiemann M, Schildberg FA, Schimisky E, Schlitzer A, Schlosser J, Schmid S, Schmitt S, Schober K, Schraivogel D, Schuh W, Schüler T, Schulte R, Schulz AR, Schulz SR, Scottá C, Scott-Algara D, Sester DP, Shankey TV, Silva-Santos B, Simon AK, Sitnik KM, Sozzani S, Speiser DE, Spidlen J, Stahlberg A, Stall AM, Stanley N, Stark R, Stehle C, Steinmetz T, Stockinger H, Takahama Y, Takeda K, Tan L, Tárnok A, Tiegs G, Toldi G, Tornack J, Traggiai E, Trebak M, Tree TIM, Trotter J, Trowsdale J, Tsoumakidou M, Ulrich H, Urbanczyk S, van de Veen W, van den Broek M, van der Pol E, Van Gassen S, Van Isterdael G, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Borstel A, von Volkmann K, Waisman A, Walker RV, Wallace PK, Wang SA, Wang XM, Ward MD, Ward-Hartstonge KA, Warnatz K, Warnes G, Warth S, Waskow C, Watson JV, Watzl C, Wegener L, Weisenburger T, Wiedemann A, Wienands J, Wilharm A, Wilkinson RJ, Willimsky G, Wing JB, Winkelmann R, Winkler TH, Wirz OF, Wong A, Wurst P, Yang JHM, Yang J, Yazdanbakhsh M, Yu L, Yue A, Zhang H, Zhao Y, Ziegler SM, Zielinski C, Zimmermann J, Zychlinsky A. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol 2019;49:1457-973. [PMID: 31633216 DOI: 10.1002/eji.201970107] [Cited by in Crossref: 391] [Cited by in F6Publishing: 332] [Article Influence: 391.0] [Reference Citation Analysis]
566 Catalán D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguillón JC, Aravena O. Immunosuppressive Mechanisms of Regulatory B Cells. Front Immunol 2021;12:611795. [PMID: 33995344 DOI: 10.3389/fimmu.2021.611795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
567 Kristensen B, Hegedüs L, Lundy SK, Brimnes MK, Smith TJ, Nielsen CH. Characterization of Regulatory B Cells in Graves' Disease and Hashimoto's Thyroiditis. PLoS One 2015;10:e0127949. [PMID: 26016954 DOI: 10.1371/journal.pone.0127949] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
568 Wilhelm AJ, Major AS. Accelerated atherosclerosis in SLE: mechanisms and prevention approaches. Int J Clin Rheumtol 2012;7:527-39. [PMID: 24672580 DOI: 10.2217/ijr.12.46] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
569 Vadasz Z, Peri R, Eiza N, Slobodin G, Balbir-Gurman A, Toubi E. The Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity. J Immunol Res 2015;2015:254245. [PMID: 26504851 DOI: 10.1155/2015/254245] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
570 Wang WW, Yuan XL, Chen H, Xie GH, Ma YH, Zheng YX, Zhou YL, Shen LS. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer. Oncotarget 2015;6:33486-99. [PMID: 26378021 DOI: 10.18632/oncotarget.5588] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 12.6] [Reference Citation Analysis]
571 Lo-Man R. Regulatory B cells control dendritic cell functions. Immunotherapy 2011;3:19-20. [PMID: 21524162 DOI: 10.2217/imt.11.34] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
572 Wei X, Jin Y, Tian Y, Zhang H, Wu J, Lu W, Lu X. Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients. Tumour Biol 2016;37:6581-8. [PMID: 26638169 DOI: 10.1007/s13277-015-4538-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
573 Kremlitzka M, Mácsik-valent B, Erdei A. Regulation of B cell functions by Toll-like receptors and complement. Immunology Letters 2016;178:37-44. [DOI: 10.1016/j.imlet.2016.07.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
574 Yoon J, Wang H, Kim YC, Yoshimoto M, Abbasi S, Morse Iii HC. Plasma cell alloantigen ENPP1 is expressed by a subset of human B cells with potential regulatory functions. Immunol Cell Biol 2016;94:719-28. [PMID: 27029896 DOI: 10.1038/icb.2016.31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
575 Stanic B, van de Veen W, Wirz OF, Rückert B, Morita H, Söllner S, Akdis CA, Akdis M. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 2015;135:771-80.e8. [PMID: 25240783 DOI: 10.1016/j.jaci.2014.07.041] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 12.1] [Reference Citation Analysis]
576 Zharkova O, Celhar T, Cravens PD, Satterthwaite AB, Fairhurst AM, Davis LS. Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology (Oxford) 2017;56:i55-66. [PMID: 28375453 DOI: 10.1093/rheumatology/kew427] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 20.0] [Reference Citation Analysis]
577 Lu Y, Liu F, Li C, Chen Y, Weng D, Chen J. IL-10-Producing B Cells Suppress Effector T Cells Activation and Promote Regulatory T Cells in Crystalline Silica-Induced Inflammatory Response In Vitro. Mediators Inflamm 2017;2017:8415094. [PMID: 28831210 DOI: 10.1155/2017/8415094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
578 Griffin DO, Rothstein TL. Human "orchestrator" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity. Mol Med 2012;18:1003-8. [PMID: 22634719 DOI: 10.2119/molmed.2012.00203] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
579 Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317. [PMID: 21677747 DOI: 10.1038/nature] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
580 Liu M, Guo Q, Wu C, Sterlin D, Goswami S, Zhang Y, Li T, Bao C, Shen N, Fu Q, Zhang X. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell Mol Immunol 2019;16:367-79. [PMID: 29563616 DOI: 10.1038/s41423-018-0010-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
581 de Masson A, Le Buanec H, Bouaziz J. Purification and Immunophenotypic Characterization of Human B Cells with Regulatory Functions. In: Vitale G, Mion F, editors. Regulatory B Cells. New York: Springer; 2014. pp. 45-52. [DOI: 10.1007/978-1-4939-1161-5_4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
582 Hanley P, Sutter JA, Goodman NG, Du Y, Sekiguchi DR, Meng W, Rickels MR, Naji A, Luning Prak ET. Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes. Clin Immunol 2017;183:336-43. [PMID: 28951327 DOI: 10.1016/j.clim.2017.09.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
583 Crickx E, Weill J, Reynaud C, Mahévas M. Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives. Kidney International 2020;97:885-93. [DOI: 10.1016/j.kint.2019.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
584 Suryani S, Tangye SG. Therapeutic implications of advances in our understanding of transitional B-cell development in humans. Expert Review of Clinical Immunology 2014;6:765-75. [DOI: 10.1586/eci.10.55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
585 Douna H, Amersfoort J, Schaftenaar FH, Kroon S, van Puijvelde GHM, Kuiper J, Foks AC. Bidirectional effects of IL-10+ regulatory B cells in Ldlr-/- mice. Atherosclerosis 2019;280:118-25. [PMID: 30500604 DOI: 10.1016/j.atherosclerosis.2018.11.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
586 Yang B, Tan X, Xiong X, Wu D, Zhang G, Wang M, Dong S, Liu W, Yang H, Li Q. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis. Immunol Res 2017;65:592-604. [DOI: 10.1007/s12026-016-8877-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
587 Li G, Wulan H, Song Z, Paik PA, Tsao ML, Goodman GM, MacEachern PT, Downey RS, Jankowska AJ, Rabinowitz YM, Learch TB, Song DZ, Yuan JJ, Zheng S, Zheng Z. Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H. pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer. PLoS One 2015;10:e0134591. [PMID: 26226399 DOI: 10.1371/journal.pone.0134591] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
588 Álvarez-Luquín DD, Arce-Sillas A, Leyva-Hernández J, Sevilla-Reyes E, Boll MC, Montes-Moratilla E, Vivas-Almazán V, Pérez-Correa C, Rodríguez-Ortiz U, Espinoza-Cárdenas R, Fragoso G, Sciutto E, Adalid-Peralta L. Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved. J Neuroinflammation 2019;16:212. [PMID: 31711508 DOI: 10.1186/s12974-019-1606-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
589 Chayé MAM, Tontini C, Ozir-Fazalalikhan A, Voskamp AL, Smits HH. Use of Toll-Like Receptor (TLR) Ligation to Characterize Human Regulatory B-Cells Subsets. Methods Mol Biol 2021;2270:235-61. [PMID: 33479902 DOI: 10.1007/978-1-0716-1237-8_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
590 Kamburova EG, Koenen HJPM, Boon L, Hilbrands LB, Joosten I. In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells: RTX Effects on B-Cell Phenotype and Function. American Journal of Transplantation 2012;12:341-50. [DOI: 10.1111/j.1600-6143.2011.03833.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
591 Dalloul A. B-cell-mediated strategies to fight chronic allograft rejection. Front Immunol 2013;4:444. [PMID: 24381571 DOI: 10.3389/fimmu.2013.00444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
592 Quarona V, Zaccarello G, Chillemi A, Brunetti E, Singh VK, Ferrero E, Funaro A, Horenstein AL, Malavasi F. CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin Cytom 2013;84:207-17. [PMID: 23576305 DOI: 10.1002/cyto.b.21092] [Cited by in Crossref: 160] [Cited by in F6Publishing: 143] [Article Influence: 20.0] [Reference Citation Analysis]
593 Rovituso DM, Duffy CE, Schroeter M, Kaiser CC, Kleinschnitz C, Bayas A, Elsner R, Kuerten S. The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients. Sci Rep 2015;5:14265. [PMID: 26387426 DOI: 10.1038/srep14265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
594 Soloski MJ, Chrest FJ. Multiparameter flow cytometry for discovery of disease mechanisms in rheumatic diseases. Arthritis Rheum 2013;65:1148-56. [PMID: 23334929 DOI: 10.1002/art.37847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
595 Hong C, Zhang T, Gao X. Recombinant murine calreticulin fragment 39-272 expands CD1dhiCD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice. Molecular Immunology 2013;55:237-46. [DOI: 10.1016/j.molimm.2013.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
596 Severa M, Zhang J, Giacomini E, Rizzo F, Etna MP, Cruciani M, Garaci E, Chopp M, Coccia EM. Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application. Mult Scler Relat Disord 2019;27:52-60. [PMID: 30317071 DOI: 10.1016/j.msard.2018.09.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
597 MacDonald KP, Hill GR, Blazar BR. Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood 2017;129:13-21. [PMID: 27821504 DOI: 10.1182/blood-2016-06-686618] [Cited by in Crossref: 127] [Cited by in F6Publishing: 95] [Article Influence: 25.4] [Reference Citation Analysis]
598 Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. Clin Cancer Res 2020;26:3345-59. [PMID: 32193227 DOI: 10.1158/1078-0432.CCR-19-3211] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 21.0] [Reference Citation Analysis]
599 Scholzen A, Sauerwein RW. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends in Parasitology 2013;29:252-62. [DOI: 10.1016/j.pt.2013.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
600 Mao H, Pan F, Wu Z, Wang Z, Zhou Y, Zhang P, Gou M, Dai G. CD19 lo CD27 hi Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal Cancer. DNA and Cell Biology 2017;36:870-7. [DOI: 10.1089/dna.2017.3814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
601 Rawlings DJ, Schwartz MA, Jackson SW, Meyer-Bahlburg A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol 2012;12:282-94. [PMID: 22421786 DOI: 10.1038/nri3190] [Cited by in Crossref: 210] [Cited by in F6Publishing: 194] [Article Influence: 23.3] [Reference Citation Analysis]
602 Kim J, Lee HJ, Yoo IS, Kang SW, Lee JH. Regulatory B cells are inversely associated with disease activity in rheumatoid arthritis. Yonsei Med J 2014;55:1354-8. [PMID: 25048496 DOI: 10.3349/ymj.2014.55.5.1354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
603 Li R, Patterson KR, Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat Immunol 2018;19:696-707. [PMID: 29925992 DOI: 10.1038/s41590-018-0135-x] [Cited by in Crossref: 144] [Cited by in F6Publishing: 125] [Article Influence: 48.0] [Reference Citation Analysis]
604 Rodgers DT, Pineda MA, McGrath MA, Al-Riyami L, Harnett W, Harnett MM. Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints. Immunology 2014;141:457-66. [PMID: 24708419 DOI: 10.1111/imm.12208] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
605 Auclair H, Ouk-Martin C, Roland L, Santa P, Al Mohamad H, Faumont N, Feuillard J, Jayat-Vignoles C. EBV Latency III-Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1-Dependent Manner. J Immunol 2019;203:1665-74. [PMID: 31434708 DOI: 10.4049/jimmunol.1801420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
606 Engelmann R, Wang N, Kneitz C, Müller-Hilke B. Bone resorption correlates with the frequency of CD5⁺ B cells in the blood of patients with rheumatoid arthritis. Rheumatology (Oxford) 2015;54:545-53. [PMID: 25193807 DOI: 10.1093/rheumatology/keu351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
607 Eiza N, Zuckerman E, Carlebach M, Rainis T, Goldberg Y, Vadasz Z. Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load. Clin Exp Immunol 2018;193:183-93. [PMID: 29665000 DOI: 10.1111/cei.13139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
608 Stożek K, Grubczak K, Marolda V, Eljaszewicz A, Moniuszko M, Bossowski A. Lower proportion of CD19 + IL-10 + and CD19 + CD24 + CD27 + but not CD1d + CD5 + CD19 + CD24 + CD27 + IL-10 + B cells in children with autoimmune thyroid diseases. Autoimmunity 2020;53:46-55. [DOI: 10.1080/08916934.2019.1697690] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
609 Żabińska M, Kościelska-Kasprzak K, Krajewska J, Bartoszek D, Augustyniak-Bartosik H, Krajewska M. Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease Activity. Cells 2021;10:1773. [PMID: 34359942 DOI: 10.3390/cells10071773] [Reference Citation Analysis]
610 Shiu KY, McLaughlin L, Rebollo-Mesa I, Zhao J, Semik V, Cook HT, Roufosse C, Brookes P, Bowers RW, Galliford J. B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection. Kidney Int. 2015;88:560-568. [PMID: 25830760 DOI: 10.1038/ki.2015.100] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
611 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
612 de Graav GN, Hesselink DA, Dieterich M, Kraaijeveld R, Verschoor W, Roelen DL, Litjens NHR, Chong AS, Weimar W, Baan CC. Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation. Front Immunol 2017;8:641. [PMID: 28620390 DOI: 10.3389/fimmu.2017.00641] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
613 Clatworthy MR. B-cell regulation and its application to transplantation. Transpl Int 2014;27:117-28. [PMID: 23909582 DOI: 10.1111/tri.12160] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
614 Muzzio D, Zygmunt M, Jensen F. The role of pregnancy-associated hormones in the development and function of regulatory B cells. Front Endocrinol (Lausanne) 2014;5:39. [PMID: 24744750 DOI: 10.3389/fendo.2014.00039] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
615 Zaimoku Y, Patel BA, Kajigaya S, Feng X, Alemu L, Quinones Raffo D, Groarke EM, Young NS. Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia. Br J Haematol 2020;190:610-7. [PMID: 32311088 DOI: 10.1111/bjh.16651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
616 Nosher S, Fuad S, Mishra N, Alrashid ZA, Rathod B, Mohan D, Basavanagowda DM, Kaur A, Heindl SE. Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis. Cureus 2021;13:e13246. [PMID: 33728194 DOI: 10.7759/cureus.13246] [Reference Citation Analysis]
617 Lin X, Wang X, Xiao F, Ma K, Liu L, Wang X, Xu D, Wang F, Shi X, Liu D, Zhao Y, Lu L. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome. Cell Mol Immunol 2019;16:921-31. [PMID: 30948793 DOI: 10.1038/s41423-019-0227-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
618 Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease. Immunol Rev 2014;259:259-72. [PMID: 24712471 DOI: 10.1111/imr.12176] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 15.9] [Reference Citation Analysis]
619 Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity 2015;42:607-12. [PMID: 25902480 DOI: 10.1016/j.immuni.2015.04.005] [Cited by in Crossref: 593] [Cited by in F6Publishing: 528] [Article Influence: 98.8] [Reference Citation Analysis]
620 Biragyn A, Lee-Chang C. A new paradigm for an old story: the role of regulatory B cells in cancer. Front Immunol 2012;3:206. [PMID: 22837759 DOI: 10.3389/fimmu.2012.00206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
621 Wang T, Mei Y, Li Z. Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus. Biomed Res Int 2019;2019:7948687. [PMID: 31240224 DOI: 10.1155/2019/7948687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
622 Morandi F, Airoldi I, Marimpietri D, Bracci C, Faini AC, Gramignoli R. CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies. Cells 2019;8:E1527. [PMID: 31783629 DOI: 10.3390/cells8121527] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
623 Lu P, Fleischmann R, Curtis C, Ignatenko S, Clarke SH, Desai M, Wong SL, Grebe KM, Black K, Zeng J, Stolzenbach J, Medema JK. Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus. Lupus 2017;27:290-302. [DOI: 10.1177/0961203317719334] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
624 Taher TE, Muhammad HA, Bariller E, Flores-Borja F, Renaudineau Y, Isenberg DA, Mageed RA. B-lymphocyte signalling abnormalities and lupus immunopathology. Int Rev Immunol 2013;32:428-44. [PMID: 23768155 DOI: 10.3109/08830185.2013.788648] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
625 Xu LZ, Yang LT, Qiu SQ, Yang G, Luo XQ, Miao BP, Geng XR, Liu ZQ, Liu J, Wen Z, Wang S, Zhang HP, Li J, Liu ZG, Li HB, Yang PC. Combination of specific allergen and probiotics induces specific regulatory B cells and enhances specific immunotherapy effect on allergic rhinitis. Oncotarget 2016;7:54360-9. [PMID: 27486985 DOI: 10.18632/oncotarget.10946] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
626 Amu S, Ruffin N, Rethi B, Chiodi F. Impairment of B-cell functions during HIV-1 infection. AIDS. 2013;27:2323-2334. [PMID: 23595152 DOI: 10.1097/qad.0b013e328361a427] [Cited by in Crossref: 60] [Cited by in F6Publishing: 30] [Article Influence: 8.6] [Reference Citation Analysis]
627 Zhang P, Hill GR. Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention. Semin Immunol 2019;44:101322. [PMID: 31640914 DOI: 10.1016/j.smim.2019.101322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
628 Liu F, Ji J, Li X, Li X, Xu J, Yue H, Zhao S, Fan H, Hou Y. Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus. Acta Biochim Biophys Sin (Shanghai) 2017;49:328-37. [PMID: 28338767 DOI: 10.1093/abbs/gmx011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
629 Xu C, Zhang M, Li K, Ni M, Bai Y, Zhang J, Song X, Wang J. CD24hiCD38hi B regulatory cells from patients with end plate inflammation presented reduced functional potency. Int Immunopharmacol 2019;70:295-301. [PMID: 30851710 DOI: 10.1016/j.intimp.2019.02.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
630 Lepse N, Abdulahad W, Rutgers A, Stegeman C, Kallenberg C, Heeringa P. Characterization of regulatory B cells in ANCA-associated vasculitis (AAV). La Presse Médicale 2013;42:755-6. [DOI: 10.1016/j.lpm.2013.02.245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
631 Satitsuksanoa P, van de Veen W, Akdis M. B-cell responses in allergen immunotherapy. Curr Opin Allergy Clin Immunol 2019;19:632-9. [PMID: 31403482 DOI: 10.1097/ACI.0000000000000580] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
632 Ran Z, Yue-Bei L, Qiu-Ming Z, Huan Y. Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases. Front Immunol 2020;11:1884. [PMID: 32973780 DOI: 10.3389/fimmu.2020.01884] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
633 Abo-Aziza FAM, Zaki AA, El-Shemy A, Elhalem SSA, Amer AS. Immunological and histopathological changes in sheep affected with cutaneous squamous cell carcinoma and treated immunotherapeutically. Vet World 2017;10:1094-103. [PMID: 29062199 DOI: 10.14202/vetworld.2017.1094-1103] [Reference Citation Analysis]
634 Mao H, Pan F, Wu Z, Wang Z, Zhou Y, Zhang P, Gou M, Dai G. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation. Int Immunopharmacol 2017;49:95-101. [PMID: 28558303 DOI: 10.1016/j.intimp.2017.05.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
635 Scalea JR, Tomita Y, Lindholm CR, Burlingham W. Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms. Front Immunol 2016;7:87. [PMID: 27014267 DOI: 10.3389/fimmu.2016.00087] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
636 Sheng JR, Rezania K, Soliven B. Impaired regulatory B cells in myasthenia gravis. J Neuroimmunol 2016;297:38-45. [PMID: 27397074 DOI: 10.1016/j.jneuroim.2016.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
637 Burton H, Dorling A. Transitional B cell subsets-a convincing predictive biomarker for allograft loss? Kidney Int 2017;91:18-20. [PMID: 28003081 DOI: 10.1016/j.kint.2016.10.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
638 Domínguez-pantoja M, López-herrera G, Romero-ramírez H, Santos-argumedo L, Chávez-rueda AK, Hernández-cueto Á, Flores-muñoz M, Rodríguez-alba JC. CD38 protein deficiency induces autoimmune characteristics and its activation enhances IL-10 production by regulatory B cells. Scand J Immunol 2018;87:e12664. [DOI: 10.1111/sji.12664] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
639 Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384:1878-1888. [PMID: 24881804 DOI: 10.1016/s0140-6736(14)60128-8] [Cited by in Crossref: 383] [Cited by in F6Publishing: 170] [Article Influence: 54.7] [Reference Citation Analysis]
640 Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends Mol Med 2017;23:615-35. [PMID: 28623084 DOI: 10.1016/j.molmed.2017.05.006] [Cited by in Crossref: 158] [Cited by in F6Publishing: 126] [Article Influence: 39.5] [Reference Citation Analysis]
641 Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. J Clin Med 2018;7:E258. [PMID: 30200565 DOI: 10.3390/jcm7090258] [Cited by in Crossref: 96] [Cited by in F6Publishing: 74] [Article Influence: 32.0] [Reference Citation Analysis]
642 Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes. Clin Exp Immunol. 2013;174:302-317. [PMID: 23865694 DOI: 10.1111/cei.12177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
643 Braza F, Soulillou J, Brouard S. Gene expression signature in transplantation tolerance. Clinica Chimica Acta 2012;413:1414-8. [DOI: 10.1016/j.cca.2012.04.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
644 Chaisri U, Tungtrongchitr A, Indrawattana N, Meechan P, Phurttikul W, Tasaniyananda N, Saelim N, Chaicumpa W, Sookrung N. Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy. PLoS One 2017;12:e0188627. [PMID: 29182623 DOI: 10.1371/journal.pone.0188627] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
645 Zhou X, Su YX, Lao XM, Liang YJ, Liao GQ. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol 2016;53:27-35. [PMID: 26631955 DOI: 10.1016/j.oraloncology.2015.11.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 11.8] [Reference Citation Analysis]
646 Karim MR, Wang YF. Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor β1 in human peripheral blood. Arch Med Sci 2019;15:1176-83. [PMID: 31572462 DOI: 10.5114/aoms.2018.77772] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
647 Alizadeh A, Santhosh KT, Kataria H, Gounni AS, Karimi-Abdolrezaee S. Neuregulin-1 elicits a regulatory immune response following traumatic spinal cord injury. J Neuroinflammation 2018;15:53. [PMID: 29467001 DOI: 10.1186/s12974-018-1093-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
648 He Y, Qian H, Liu Y, Duan L, Li Y, Shi G. The roles of regulatory B cells in cancer. J Immunol Res 2014;2014:215471. [PMID: 24991577 DOI: 10.1155/2014/215471] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
649 Busse M, Campe KJ, Redlich A, Oettel A, Hartig R, Costa SD, Zenclussen AC. Regulatory B Cells Are Decreased and Impaired in Their Function in Peripheral Maternal Blood in Pre-term Birth. Front Immunol 2020;11:386. [PMID: 32265904 DOI: 10.3389/fimmu.2020.00386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
650 Biragyn A, Aliseychik M, Rogaev E. Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol 2017;39:283-94. [PMID: 28083646 DOI: 10.1007/s00281-016-0615-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
651 Menon M, Rosser EC, Mauri C. Identification and Isolation of Regulatory B Cells in Mouse and Human. Methods Mol Biol 2019;1899:55-66. [PMID: 30649765 DOI: 10.1007/978-1-4939-8938-6_5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
652 Ziętara N, Łyszkiewicz M, Krueger A, Weiss S. B-cell modulation of dendritic-cell function: signals from the far side. Eur J Immunol 2014;44:23-32. [PMID: 24307285 DOI: 10.1002/eji.201344007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
653 Sanz I. Rationale for B cell targeting in SLE. Semin Immunopathol 2014;36:365-75. [PMID: 24763533 DOI: 10.1007/s00281-014-0430-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
654 Furuzawa-Carballeda J, Hernández-Molina G, Lima G, Rivera-Vicencio Y, Férez-Blando K, Llorente L. Peripheral regulatory cells immunophenotyping in primary Sjögren’s syndrome: a cross-sectional study. Arthritis Res Ther. 2013;15:R68. [PMID: 23800367 DOI: 10.1186/ar4245] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
655 Rao M, Valentini D, Poiret T, Dodoo E, Parida S, Zumla A, Brighenti S, Maeurer M. B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis. Clin Infect Dis 2015;61Suppl 3:S225-34. [PMID: 26409285 DOI: 10.1093/cid/civ614] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
656 Nepom GT, St Clair EW, Turka LA. Challenges in the pursuit of immune tolerance. Immunol Rev. 2011;241:49-62. [PMID: 21488889 DOI: 10.1111/j.1600-065x.2011.01003.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
657 Goode I, Xu H, Ildstad ST. Regulatory B cells: the new "it" cell. Transplant Proc 2014;46:3-8. [PMID: 24216174 DOI: 10.1016/j.transproceed.2013.08.075] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
658 Ringelstein-Harlev S, Avivi I, Fanadka M, Horowitz NA, Katz T. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation. Cancer Immunol Immunother 2018;67:739-48. [PMID: 29450641 DOI: 10.1007/s00262-018-2128-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
659 Mizoguchi A, Mizoguchi E. Animal models of IBD: linkage to human disease. Curr Opin Pharmacol 2010;10:578-87. [PMID: 20860919 DOI: 10.1016/j.coph.2010.05.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
660 Wilkinson MGL, Rosser EC. B Cells as a Therapeutic Target in Paediatric Rheumatic Disease. Front Immunol 2019;10:214. [PMID: 30837988 DOI: 10.3389/fimmu.2019.00214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
661 Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice. PLoS One. 2014;9:e83575. [PMID: 24465383 DOI: 10.1371/journal.pone.0083575] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
662 Grützke B, Hucke S, Gross CC, Herold MV, Posevitz-Fejfar A, Wildemann BT, Kieseier BC, Dehmel T, Wiendl H, Klotz L. Fingolimod treatment promotes regulatory phenotype and function of B cells. Ann Clin Transl Neurol 2015;2:119-30. [PMID: 25750917 DOI: 10.1002/acn3.155] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
663 Smets I, Prezzemolo T, Imbrechts M, Mallants K, Mitera T, Humblet-Baron S, Dubois B, Matthys P, Liston A, Goris A. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis. Front Immunol 2021;12:676619. [PMID: 34122439 DOI: 10.3389/fimmu.2021.676619] [Reference Citation Analysis]
664 Cao T, Shao S, Fang H, Li B, Wang G. Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses. Front Immunol 2019;10:1746. [PMID: 31428090 DOI: 10.3389/fimmu.2019.01746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
665 Khoder A, Alsuliman A, Basar R, Sobieski C, Kondo K, Alousi AM, Szydlo R, Muftuoglu M, Shaim H, Apperley JF, Gokdemir E, Cooper N, Mehta RS, Marin D, Champlin R, Shpall E, Rezvani K. Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease. Front Immunol 2017;8:1937. [PMID: 29375566 DOI: 10.3389/fimmu.2017.01937] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
666 Vitale G, Mion F, Pucillo C. Regulatory B cells: evidence, developmental origin and population diversity. Mol Immunol. 2010;48:1-8. [PMID: 20950861 DOI: 10.1016/j.molimm.2010.09.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
667 Shao Y, Lo CM, Ling CC, Liu XB, Ng KT, Chu AC, Ma YY, Li CX, Fan ST, Man K. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett 2014;355:264-72. [PMID: 25301451 DOI: 10.1016/j.canlet.2014.09.026] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 8.6] [Reference Citation Analysis]
668 Zhang X. Regulatory functions of innate-like B cells. Cell Mol Immunol. 2013;10:113-121. [PMID: 23396472 DOI: 10.1038/cmi.2012.63] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
669